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Abstract 
 
 
The effects of old age on musculoskeletal structure and function have been 
characterised in the literature through cross-sectional studies, comparing data from 
young and older adults in an attempt to uncover the mechanisms behind decreases in 
muscle mass and function. However, such work is prone to potential bias associated 
with differences in changes in lifestyle and genotype during human ageing. 
Longitudinal studies can overcome such bias, though these are of in the minority and 
generally outline relatively simple measures in larger epidemiological studies.     
The overall aim of the work described in this thesis was to assess longitudinal changes 
in muscle mass and function, and how these influenced the ability to perform daily life 
activities over a 5-year period in older individuals. Characterising a more robust model 
of ageing than its cross-sectional counterparts in more detail than previously reported. 
This aim was addressed through several objectives that are described across the 
Chapters. 
In Chapter 2, we highlight that the use of dual-energy X-ray absorptiometry (DXA) to 
track changes in muscle mass is a viable method when compared to magnetic 
resonance imaging (MRI), though DXA exhibited a positive intercept with MRI and 
therefore consistently overestimated muscle volume.  
It was reported in Chapter 2 that over the 5-year period there might be an accelerated 
decline in muscle mass, with no difference in relative rate of muscle loss between 
genders or baseline muscle mass. Loss of muscle mass in ageing is related to deficits 
in functional capacity, in Chapter 3 the contribution of reduced voluntary activation, 
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fibre atrophy and fibre loss to muscle weakness are investigated. Muscle quality, 
measured by patella tendon specific force was found to contribute significantly to the 
loss of age-related muscle weakness in early ageing, though loss of muscle mass was 
found to be the main cause.    
The objective of Chapter 4 was to investigate the influence of muscle weakness on 
mobility performance. Significant decreases in 6-min walk and timed up and go were 
noted, with changes in muscle power being the key contributor to this change. Rather 
than the intrinsic slowing of the muscle seen in early ageing, power loss was primarily 
due to reductions in maximal voluntary contraction. 
The main conclusion of this work was that free-living septuagenarian’s show an 
accelerated decline in muscle mass and functional performance over a 5-year period 
compared to cross sectional data previously reported, suggesting upon reaching the 
eighth decade humans neuromuscular system ages at an faster rate than preceding 
decades. The preferential atrophy of type II and loss of fibres are the key contributors 
to this loss of mass. These findings highlight the need for septuagenarians in relatively 
good health to have appropriate interventions designed to mitigate these age-related 
changes.  
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‘The Spirit that seeks to triumph in adversity and arms a man against the shock of 
battle is called Morale. The Moral of an individual or group is not necessity a 
measure of happiness or contentment; it is a measure of the cohesion and power of 
that individual’s or group’s resolve to pursue it object come what may.’ 
 
General Sir Rupert Smith  
 
 
‘A moth-eaten rag on a worm eaten pole, It does not look likely to stir a man’s soul, 
‘Tis the deeds that were done ‘neath the moth eaten rag, When the pole was a staff, 
and the rag was a flag.’ 
 
General Sir Edward Bruce Hamley  
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1.1 General introduction  
Skeletal muscle contributes around 40% of total body mass and serves out many 
different roles in the body, most notably the production of force which allows humans 
to execute movement, as well as thermoregulation, energy metabolism, endocrine and 
paracrine functions (Pedersen, 2009). As humans age, skeletal muscle mass declines 
progressively into later life. This process is known as muscle atrophy and it is a major 
cause of muscle weakness. This muscle weakness is associated with an impaired 
mobility that in turn has a negative impact on the quality of life and ultimately 
contributes to an inability to live independently (Goodpaster et al., 2006, Doherty, 
2003a). The ageing-related degenerative loss of muscle mass and function has been 
termed Sarcopenia (Greek, meaning “poverty of the flesh”), however this umbrella 
term does not do justice to complex and multi-faceted nature of muscle related 
changes seen with ageing. Understanding this process is crucial as modern society 
has an increased proportion of older individuals, due to improved healthcare and living 
conditions. 
The declining muscle mass with advancing older age is in part due to older people 
slowing down and moving less which causes a type of “disuse” atrophy. But, this is not 
the only cause because muscle mass, strength and other indices of muscular 
performance decline even in athletic older people from their fourth decade of life 
(Berthelot et al., 2012, Rittweger et al., 2009), which is very similar to the patterns 
seen in the general population (Janssen et al., 2000c). The declines are gradual, 
meaning that a substantial amount of muscle tissue and maximal function can be lost 
over several decades before it begins to interfere with a person’s ability to perform 
essential daily tasks. Ultimately, a “disability threshold” is crossed and beyond this the 
functional capacity of muscle function is impaired to such an extent that it impacts 
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negatively on daily life activities (Mithal et al., 2013, McPhee et al., 2016, Degens and 
McPhee, 2013). By this point, the risk of frailty, social isolation and morbidity are high 
(Jette and Jette, 1997). These issues highlight the importance of maintaining muscle 
force and velocity in old age to extend quality of life (Degens and Korhonen, 2012). 
Much research has focused on cross-sectional changes in muscle function with age, 
which typically compares observations made in young adult with those made in older 
adults. Far fewer studies have assessed the longitudinal changes in muscle seen in 
ageing, and those studies that did determine longitudinal changes tend to be of 
epidemiology designs that cannot provide a detailed analysis. Longitudinal studies can 
circumvent bias related to genetic and/or environmental differences between people 
in cross-sectional studies.   
1.2 Skeletal Muscle  
Deliberate movement is a key function of skeletal muscle, alongside breathing and 
retaining posture (Pedersen, 2009). Skeletal muscle can be understood and studied 
in terms of its structure and function that enable force and power generation.   
Structure  
Skeletal muscle is made up of serial bundles of elongated, multinucleated cells also 
known as myofibres. The main proteins in muscle fibres are the two contractile 
proteins; actin (forming the thin filament) and myosin (forming the thick filament). The 
regular arrangement of the filaments along the length of the muscle fibre gives skeletal 
muscle a banded, or striated look (Jones and Round, 1990). Myosin can be broken 
down in to a globular head which combines with actin, the tail which combines with 
other myosin proteins to form thick filaments and the flexible region known as the S2 
portion. Myosin filaments are attached to the Z line by the protein titin. Actin filaments 
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connect to the Z line structure via α-actinin. The other component of the thin filament 
is tropomyosin, which blocks the myosin binding sites until calcium binds to troponin 
C (Jones et al., 2004). These elements form the myofilaments, which are arranged in 
regular formations throughout the myofilament, constructing a series of sarcomeres. 
Myofilaments are aligned serially to form a myofibril. Each myofibril is surrounded by 
transverse tubules (T tubules) and the sarcoplasmic reticulum, with around 2000 
myofilaments forming a myofibril (Jones and Round, 1990). Myofibril then form muscle 
fibres, which aligned serially as bundles form the whole muscle, which connect via 
tendons to the bone. Each individual muscle fibre has one single connection and the 
neuromuscular junction to a motor neuron of the nervous system. Instructions 
transmitted along the nervous system to the muscle lead to muscle fibre contractions 
and thus force generation to cause movement of skeletal elements relative to each 
other. 
Mechanics of contraction 
The functional unit of skeletal muscle is the motor unit, which consists of the motor 
neuron in the spinal cord, its axon that extends towards the target muscle, and the 
muscle fibres it innervates (Sherrington, 1925). Each motor neuron innervates a 
number of muscle fibres of the same phenotype (slow or fast) distributed throughout 
the target muscle, ensuring even force distribution throughout the muscle and avoids 
localised intense activation (Edström and Larsson, 1987). The number of fibres 
innervated by each motor unit is dependent on the type of movement required (finer 
movement require smaller motor units, while large and powerful movements require 
large motor units) and the size of the muscle (Jones and Round, 1990). Where the 
motor neuron meets the muscle fibre there is a synaptic connection known as the 
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neuromuscular junction.  When action potentials from the motor neuron reach the 
neuromuscular junction, the voltage sensitive channels open and calcium enters into 
the synapse. This in turn releases acetyl choline (ACh) into the synaptic cleft, 
increasing permeability to Na+ of the postsynaptic membrane which leads to a rapid 
depolarisation of the muscle membrane. The action potential then propagates over the 
muscle membrane and reaches the interior of the fibres via the invaginations of the 
plasma membrane, called T tubules. Consequently ryanodine receptors (calcium 
channels) open on the sarcoplasmic reticulum following the conformation change of 
the voltage-gated dihydropiridine receptors (Huang et al., 2011). Calcium diffuses to 
the myofilaments, where it binds to troponin C and induces a conformational change 
in tropomyosin exposing the myosin binding sites. The myosin head then binds to 
actin, the bond is strengthened through the release of inorganic phosphate and during 
the release of adenosine di-phosphate the power stroke occurs, causing the filaments 
to ‘slide’ along each other, resulting in shortening of the muscle fibre and production 
of force. Myosin detaches from actin when adenosine tri-phosphate binds, which is 
then hydrolysed to adenosine di-phosphate and inorganic phosphate, returning the 
myosin head to its original position. This process is known as cross bridge cycle and 
the entire process is identified as excitation contraction coupling (Huxley, 1957).   
Power Generation 
When cross bridge cycling occurs, the muscle produces force and shortens (at a 
variable velocity), though isometric muscle contractions occur without appreciable 
shortening between insertion and origin. Force multiplied by velocity equals power, 
and this production of power allows movement of the skeletal system. This relationship 
is outlined by the Hill equation (Hill, 1938). 
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(P + a) * (V + b) = (P0 + a) * b 
where P0 is the maximal isometric force, and a and b are constants, V the velocity of 
shortening as a proportion of the maximal shortening velocity (Vmax) and P the force 
as a proportion of P0. Therefore the product of force (N) and velocity (m·s-1) during 
contraction gives power (N·m·s-1) (Degens, 2018). Production of muscle force is 
proportional to its cross-sectional area, while velocity of shortening is proportional to 
the length of the muscle (although differences occur across different fibre types). 
Therefore, a muscle that is thin and long will shorten quickly but yield low force, while 
the opposite is true for thick and short muscles (Jones et al., 2004).   
Fibre Type 
The fibre type composition is an important determinant of the activation time and 
relaxation time. There are three pure fibre types in human skeletal muscle: type I, type 
IIa and type IIx. Additionally, some fibres are hybrid fibres containing more than one 
myosin heavy chain (MHC) isoform. The difference in MHC isoforms defines the 
contractile properties of each fibre type (Harridge et al., 1996), though other contractile 
proteins, such as tropomyosin have also been shown to have fast and slow isoforms 
(Tajsharghi, 2008). Type IIa/IIx are both more powerful but fatigue more easily due to 
greater anaerobic respiration, while type I are more resistant to fatigue with the cost 
of being relatively slow (Jones et al., 2004). The maximal shortening velocity is as 
much as 7x higher in fast than slow fibres (Bottinelli et al., 1996, Widrick et al., 1996, 
Gilliver et al., 2009, Degens and Larsson, 2007).  
Muscle architecture 
Muscle architecture is key to the understanding of mechanical properties of muscle, 
giving further insight into the force-velocity and length force relationship. The 
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physiological cross-sectional area (PCSA) was first outlined by Haxton (1944) and is 
the cross section of the muscle perpendicular to its fibres, allowing an estimation of 
force proportional to the number of fibres. The addition of muscle and joint architecture 
allow the influence of external torque to be accounted for and allows for better 
estimates of muscle quality and is known as specific force, this then allows for the 
force velocity characteristics of the muscle to be obtained (Degens et al., 2009b).  
1.3 Changes in muscle with age 
The ageing process is associated with a general reduction of skeletal muscle mass, 
termed sarcopenia (Rosenberg, 1989a). The loss of muscle mass is associated with 
weakness, reduced mobility, balance and neuromuscular control, causing older 
individuals to suffer a decreased quality of life, progressing from an independent to 
dependant lifestyle (Russ et al., 2012). These consequences of muscle wasting can 
be detected even in healthy older people and can lead to a reduced quality of life 
(Doherty, 2003a) also manifesting itself with increased incidence in physical disability 
and mortality (Hairi et al., 2010a, Janssen et al., 2002).  
As the percentage of people older than 65 years in Western societies continues to 
increase, it is becoming ever more important to design effective strategies to temper 
or even reverse the decline in muscle function associated with ageing. The much cited 
cost of this age related decline into disability is estimated to cost the United States 
health service around $18.5 billion in 2000 (Janssen et al., 2004). More recent work 
showed individuals defined with low skeletal muscle mass index consistently having 
higher associated costs in a wide range of settings whether these be direct or indirect 
healthcare costs (Norman and Otten, 2018). A cohort of older people (71-80 years) in 
the UK classified with muscle weakness was shown to cost £4592 per annum 
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compared to £1885 per annum in those without muscle weakness, therefore the 
financial cost to the UK is currently estimated at £2.5 billion (Pinedo-Villanueva et al., 
2019). With the cost to the United States health service now estimated to be $40.4 
billion (Goates et al., 2019). The global proportion of older individuals continues to 
grow, the financial burden will continue to rise as the direct and indirect health care 
costs of sarcopenia increase (United-Nations, 2012, McPhee et al., 2016, Norman and 
Otten, 2018).  There are many factors that contribute to sarcopenia including altered 
hormonal status, inflammation, oxidative stress, altered protein intake and anabolic 
resistance, all have an effect on how humans age, leading to issues with these 
confounding factors particularly in cross-sectional studies (Narici and Maffulli, 2010, 
Degens, 2007, Larsson et al., 2019). There is evidence that the decrease in muscle 
function with age is proportionally more than the loss of muscle mass, leading to the 
suggestion that there is a lower ‘quality’ of remaining muscle tissue in old age (Degens 
et al., 2009a, Canepari et al., 2010, Morse et al., 2005a). We must also consider that 
those in old age represent many specific cohorts (good health/poor health), all with 
differing rates of ageing due to multiple factors and it is important that we are able to 
characterise such phenomena within these cohorts.  
Age-related changes in Muscle Mass 
Whole body muscle mass loss between the ages of 18 and 88 is around 27% (Janssen 
et al., 2000c). This loss of mass can mainly be attributed to a decline in numbers of 
muscle fibres and to atrophy of remaining fibres, particularly the type 2 fibres (Lexell 
et al., 1988). It has also been reported that muscle mass loss is not uniformly spread 
throughout the body, with the upper body seemingly less affected from losses than the 
leg muscles (Janssen et al., 2000c). It would also seem that the four muscles of the 
quadriceps are more affected than other muscles of the legs (Maden-Wilkinson et al., 
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2013b, Abe et al., 2014b). In fact, extensor muscles in general seem to suffer from 
more atrophy than flexors (Candow and Chilibeck, 2005, Abe et al., 2014a), with the 
quadriceps possibly losing up to 40% of its volume by the ninth decade (Macaluso et 
al., 2002, Young et al., 1984). This loss of muscle mass seemingly starts after the age 
of 30 years (Gallagher et al., 1997) and constant progressive losses are seen when 
entering the sixth decade of life (Janssen et al., 2000c, Doherty, 2003a, Deschenes, 
2004). 
Men have larger muscles that produce higher forces than women (1.5-2 times higher) 
(Goodpaster et al., 2001, Miller et al., 1993), though whether the rate of atrophy is 
greater is up for debate with it thought to be similar (Frontera et al., 2000a, Koster et 
al., 2011) or faster in men (Delmonico et al., 2009a, Hughes et al., 2001b). While it is 
unequivocal that in absolute terms men’s muscle mass declines at a faster rate, 
because of an initial larger muscle mass they will reach the disability threshold later 
than women will. Therefore, older women may be more susceptible to mobility issues 
and an increased likelihood of sarcopenia (Degens and McPhee, 2013, Narici and 
Maffulli, 2010). 
When looking at the loss of muscle mass, there is a particular interest in the knee 
extensor muscles, due to their function in movement and functional limitation has been 
reported to be related with a small quadriceps mass (Buford et al., 2012). The use of 
Magnetic resonance imaging (MRI) allows for the thigh to be separated into its 
constituent muscles (Buford et al., 2012, Narici et al., 1992, Ogawa et al., 2012).  MRI 
has allowed for differential changes in these muscles to be observed, such as a faster 
rate of atrophy of the quadriceps muscle with a relative maintenance of the hamstrings 
and adductors muscle mass during ageing (Janssen et al., 2000c, Macaluso et al., 
2002, Ogawa et al., 2012)       
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Power loss 
It seems that the age-related changes in muscle power begin earlier than the observed 
changes in muscle mass. When power decreases below a certain level it will impact 
on the ability of to perform tasks of daily life (McPhee et al., 2016, Degens and 
McPhee, 2013) and even in healthy older people. Reductions in chair rise time and 
walking speed are reported, that can partly be attributed to a loss of muscle power but 
not loss of muscle mass (Maden-Wilkinson et al., 2015). The rate of loss of power 
appears similar in men and women (Maden-Wilkinson et al., 2015, Runge et al., 2004). 
Figure 1.1 illustrates how age-related decrements in force and velocity both contribute 
to the loss of power with age. Since both force and velocity determine the power 
generated, it is understandable that muscle power is more strongly correlated with 
performance of daily life activities than muscle force or mass (Maden-Wilkinson et al., 
2015, Reid and Fielding, 2012). Whether these observations actually precede 
detectable changes in electrophysiological or morphological measures is debatable, 
as these may be missed due to lack of sensitivity and precision in these measures at 
this point (Larsson et al., 2019).  
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Figure 1.1. Illustration of the force (solid lines) and power (dashed lines) velocity relationships in young 
(blue lines) and old (red lines) muscles, where the maximal velocity of shortening and force are set at 
100% in young muscles. For the illustration, a 25% lower maximal force and a 40% lower maximal 
shortening velocity in old than young muscles are assumed, while the curvature is kept constant. This 
resulted in a 53% lower maximal power and a lower velocity at which maximal power is generated, 
illustrated by arrow A. Arrow B illustrates that to generate the same force, older muscles must contract 
slower. Both effects most likely contribute to some extent, but not solely, to the slowing of movement in 
old age (Degens, 2018). 
 
Force, power and velocity of shortening decrease with age (Edstrom and Larsson, 
1987, Degens et al., 1998, Cotter et al., 1989), independent of protein composition of 
the fibre (Degens and Larsson, 2007). However, it has been shown that there is a 
disparate change in muscle force and power generating capacity on the one hand and 
size on the other hand, suggesting that not only do muscles atrophy but the contractile 
properties are also compromised (Degens et al., 2009b).  
Fibre type and size 
It is generally considered that there is no shift in numerical muscle fibre proportions 
with ageing, but that there is increased areal proportion of type I fibres, due to 
preferential atrophy of type II fibres (Andersen, 2003, Barnouin et al., 2017b). This 
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preferential type II atrophy also leads to whole muscle atrophy and will undoubtedly 
also contribute to the age-related loss of power, as type II fibres are more powerful 
than type I fibres (Gilliver et al., 2009). However, the decrease in the areal proportion 
of type II fibres (e.g. from 57.5 at 24 years to 51.5% at 70 years) is not large (Barnouin 
et al., 2017b) and the changes in fibre type composition thus contributes a small part 
to the loss of muscle power seen with ageing (Degens, 2018).  
Architecture 
During ageing the muscle architecture changes as a consequence of the muscle fibre 
atrophy and loss of fibres. The most obvious consequence is a reduction in the cross-
sectional area of the muscle, but also the pennation angle of the fascicles decreases. 
This reduction in pennation angle will attenuate some of the age-related reduction in 
force and power generating capacity of the muscle as the fascicles are more aligned 
with the line of pull (Degens et al., 2009b). Older muscles will also have a larger 
proportion of fat infiltration that contributes to the lower specific tension often observed 
in older than younger muscles (Degens and McPhee, 2013, Delmonico et al., 2009a, 
Goodpaster et al., 2001, Power et al., 2014). 
Specific force reduction 
The fact that muscle maximal force declines more than muscle mass in old age has 
led to considerable interest in the concept of “muscle quality”, meaning the force 
generated per unit muscle mass. In whole muscle, this has been termed “specific 
force”. Various explanations have been proposed, including an increase in fat 
infiltration of the muscle as well as a reduction in specific force of single muscle fibres, 
known as the specific tension (Canepari et al., 2010, Larsson et al., 1997, D'Antona et 
al., 2007). There is evidence that a reduced specific tension is due to oxidative-
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damage causing alterations to the myosin head (Lowe et al., 2004, Lowe et al., 2001) 
and an age-related decrease in the myosin concentration in muscle fibres (D'Antona 
et al., 2003). One type of post-translational modification may be myosin glycation that 
has been reported in muscles of older individuals and in diabetes patients (Syrovy and 
Hodny, 1992). Indeed, glycation of myosin results in a reduced ability of myosin to 
propel actin in an in vitro motility assay  (Ramamurthy et al., 2001). It remains to be 
seen whether myosin glycation is indeed a factor that contributes to the age-related 
muscle slowing. 
Neural regulation 
Another potential cause of the age-related reduction in specific force is a lower ability 
to voluntary activate a muscle (Morse et al., 2004). In addition, some fibres may not 
be activated at all, as they may have become denervated due to motor neuron loss. 
In a rodent study, this explained an 11% reduction in specific tension in old compared 
to young rats (Urbanchek et al., 2001). The good news is that most denervated fibres 
will eventually be re-innervated by sprouting from axons from surviving motor neurons, 
but this process is incomplete, resulting in a decrease in motor units and an increase 
in remaining motor unit size (Piasecki et al., 2018b, Piasecki et al., 2016b). 
Causes of muscle weakness 
Part of the age-related decrease in muscle mass may be caused by the progressive 
decrease in levels of physical activity as humans age (Ingram, 2000, Degens and 
Alway, 2006). In fact, one of the most intriguing properties of skeletal muscle is its 
enormous plasticity, reflected by the ability to respond to altered functional demands 
(Larsson et al., 2019). For instance, muscle adapts to endurance training with 
increased fatigue resistance and aerobic capacity, while repeated overloading causing 
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increased muscle strength and size (Jones et al., 1989, Salmons and Henriksson, 
1981). On the other hand, disuse leads to atrophy and weakness. 
Older muscles may have a compromised ability to maintain muscle mass, with 
reduced myofibrillar protein synthesis rate leading to reduced quality and quantity of 
motor protein due to disuse in older age (Larsson et al., 2019). This is part of a the 
larger issue of anabolic resistance shown with ageing, occurring from a blunting of the 
response from anabolic stimuli, these being the ingestion of amino acids and 
contractile loading of skeletal muscle (Breen and Phillips, 2013). Though it has been 
reported that increasing the volume of exercise at either 40% or 75% of one repetition 
max is able to overcome anabolic resistance to some extent (Kumar et al., 2012), with 
it being consistently shown that older individuals do respond with hypertrophy to 
resistance exercise (Fiatarone et al., 1990, Harridge et al., 1998). Not only force, but 
also the maximal shortening velocity of a muscle may be influenced by physical activity 
levels, where a high level of activity has also been linked to higher shortening velocity 
and specific tension in single muscle fibres (D'Antona et al., 2007). Undoubtedly, 
reduced levels of physical activity do contribute to the apparent age-related loss of 
muscle mass and strength. However, it is not the whole story as even masters athletes 
exhibit similar percentage annual loss in performance in a wide range of athletic events 
(Ganse et al., 2018) and the fibre type shift is opposite to that seen in disuse (Degens 
and Alway, 2006).   
Besides lower physical activity levels, other factors must contribute to muscle ageing 
leading to the reduction in muscle quality observed. One of those, the ongoing 
denervation/re-innervation process due to motor neuron loss, is already described. It 
is, however, unclear what causes this loss of motor neurons. Fat and fibrotic infiltration 
during ageing with ageing is thought to decrease muscle quality, through the 
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impairment of force generation (particularly the lateral transfer of force) (Ramaswamy 
et al., 2011). Muscle architecture in ageing is influenced by dysregulated muscle 
remodelling, with myogenic progenitor cells switching to a fibrotic outcome (Shefer et 
al., 2006), possibly signifying intramuscular fat and fibrotic deposits are due to 
changes in satellite cell signalling (Vertino et al., 2005). Low-grade systemic 
inflammation in old age may be such a factor and has been suggested to play an 
important role in the ageing-related muscle wasting (Degens, 2010). Some of these 
circulating factors seem indeed to be linked to muscle weakness such as interleukin 6 
(IL-6) and tumour necrosis factor α (TNFα) (Visser et al., 2002). Satellite cells key in 
muscle regeneration may have reduced ability to self-renew during ageing (Shefer et 
al., 2006). Possibly leading to apoptosis or senescence, due to an increase in 
proliferation (Chakkalakal et al., 2012, Sousa-Victor et al., 2014). Contributing to 
impaired regeneration of muscle with ageing, alongside a possible contribution to 
neuromuscular degeneration, leading to decreases in muscle quality (Carlson et al., 
2001, Liu et al., 2017).  It is also important to consider changes in reactive oxygen 
species (ROS) and leading to alterations in antioxidant defence systems seen with 
ageing. Part of the loss of the regeneration capacity of satellite cells could be the 
increase in ROS seen in older subjects, leading to damage of cellular macromolecules, 
suggesting redox balance plays an important role in muscle ageing (Minet and Gaster, 
2012). In skeletal muscle, the antioxidant defence system has been shown to be 
upregulated during ageing (Sullivan-Gunn and Lewandowski, 2013). However, there 
is no further increase in antioxidant enzyme activities normally elicited from muscle 
contraction in older muscle, leading to a potential increase in oxidative damage to 
muscle cells (Vasilaki et al., 2006). The increase in ROS and attenuated antioxidant 
defences is thought to contribute to mitochondrial dysfunction. The increase in ROS 
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lead to mutations in mitochondrial DNA, impairing the electron transport chain due to 
the production of dysfunctional components, which in turn leads to a further increase 
in ROS (Miquel et al., 1980). Exacerbating the damage to muscle cells in ageing, 
leading to muscle atrophy in humans (Bua et al., 2006). During ageing there is also a 
decrease in hormones, such as a reduction in insulin-like growth factor-I (IGF-I), that 
may lead to a reduced anabolic environment (Lamberts et al., 1997). In addition, the 
reduction in sex hormones have been linked with muscle weakness in both older men 
and women (Van Vliet et al., 2005, Phillips et al., 1993). These alterations in the profile 
of circulating hormones may well contribute to the anabolic resistance seen in older 
individuals (Rennie, 2009), with studies showing a need for an increased protein 
consumption for a positive effect on lean mass in undernourished older individuals 
(Park et al., 2018).  
1.4 Quantification of Body Composition in Humans 
In the past four decades there have been considerable advancements in the study of 
body composition (BC). It is now possible to measure body organs, tissues and cells 
in very high detail (Malina, 2007). BC allows for accurate assessment of organs, 
tissues and cellular compartments for clinical diagnosis and to identify where 
intervention may be needed (Lee and Gallagher, 2008). Different techniques of 
assessments are available and they each have their merits and their weaknesses. A 
five-level framework can describe whole body, tissue, molecular, and atomic aspects 
of the human body. Often BC is represented in terms of protein, lipids, carbohydrate 
(usually dismissed due to small amounts held), minerals and water. To estimate body 
mass from these, the following equation is used: 
 
Body mass = water + protein + mineral + lipids (Malina, 2007) 
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Generally, a two-compartment model is the preferred method of partitioning body 
mass: fat mass (FM) and fat free mass (FFM). Some models separate FFM into 
muscle, bone mineral and connective tissue. Of these components FM, and muscle 
are the most readily influenced by diet and activity (Malina, 2007). Clinicians and 
researchers are interested in finding an optimal balance between FFM, FM and total 
body mass to achieve health in the general population. This information can help in 
the design of interventions to keep older individuals physically independent and more 
robust as they age. The age related alterations in BC, especially the loss of muscle 
mass, not only leads to muscle weakness as discussed above, but can also cause 
metabolic problems (Tzankoff and Norris, 1977). BC is also an indicator of nutritional 
status and provides information on possible instances of malnutrition. Therefore, the 
accurate tracking of body composition throughout the lifespan is imperative to help 
achieve better health outcomes within populations. This can only be achieved through 
the use of a consistent and accurate method of BC estimation.    
Computer tomography (CT) and MRI offer the greatest level of detail when assessing 
BC, providing an estimate of muscle volume, through the analysis of muscle cross-
sectional slices, which can then be used to construct the full volume of the muscle. CT 
and MRI have also been used to quantify subcutaneous and intramuscular fat 
infiltration. CT and MRI are considered the “gold standard” to estimate skeletal muscle 
size and body composition in populations including children (de Ridder et al., 1992), 
healthy adults (Ross et al., 1996) and the elderly (Baumgartner et al., 1992). However, 
the acquisition of data from MRI and CT scanning is an expensive and time-consuming 
process. DXA is a quicker technique, but provides a 2-dimensional estimate of lean 
body mass, fat mass and bone mineral content. In all three modalities aforementioned, 
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there could also be issues with scanning larger individuals and it may be difficult to 
define water and intramuscular lipids. 
Dual-Energy X-Ray Absorptiometry  
The principle of DXA is that X-rays are absorbed to a different extent by different 
tissues. To perform the measurement a low and high pseudomonoenergetic beam is 
produced by a high-speed fan beam scanner X-ray tube and the absorption of the X-
ray measured (Andreoli et al., 2009). DXA was initially used for the assessment of 
bone mineral density and diagnosing osteoporosis and osteopenia. It has now become 
clear that it can also be used to collect whole or regional data on body composition 
and because of its relative ease it has become a popular modality. However, there are 
some issues with the use of DXA to assess body composition, as the algorithms may 
be valid for young people, but not directly transferred for older people, due e.g. to an 
age-related increase in connective tissue, intramuscular fat and subcutaneous tissue. 
DXA sees non-adipose components of fat tissue, connective tissue (Wang et al., 1996) 
and non-mineral components of bone (Heymsfield et al., 1990) as FFM. It must also 
be noted that DXA measurements assume that the hydration status of FFM is 73%, 
but this can vary from 67-85% dependent on hydration status (Pietrobelli et al., 1998). 
This bias is likely to be small as it has been reported that no significant effect was seen 
on total fat percentage when hydration ranged from 68% - 78% (Kelly et al., 1998). 
DXA scans are much more accessible, easier to use and interpret, as well as having 
considerably lower costs than MRI scanners. However, DXA may overestimate fat and 
mineral content, is unsuitable to distinguish separate muscle groups and lacks 
therefore the ability to asses muscle quality (Shaw et al., 2007). There is also an 
exposure to radiation when conducting DXA (ranging from 0.04 – 0.86 mrem), 
dependent on the make and model of the scanner and the dimensions of the patient 
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(Lee and Gallagher, 2008). However, this dose is much lower than normal daily 
exposure (1.69 mrem). 
The first studies looking into the validity of DXA used the measure of whole body 
potassium to correlate against DXA measurements, as whole body potassium 
indicates the lean mass of a person (Womersley et al., 1972). It was found that 
appendicular lean mass was strongly correlated to total body potassium (r=0.94) 
(Heymsfield et al., 1990), though DXA was found to overestimate muscle mass when 
compared to measures by CT, with this overestimation increasing with increasing 
muscle mass (Heymsfield et al., 1990). It has been suggested that the overestimate 
of lean mass by DXA is due to assumptions made for protein or other material in 
adipose tissue and bone, therefore skewing the measure of lean mass (Heymsfield et 
al., 1990, Loenneke et al., 2016, Abe et al., 2015). However, adjustments to account 
for fat infiltration, none-bone mineral content and connective tissue do no remove this 
bias (Heymsfield et al., 1990, Kent-Braun et al., 2000) 
Magnetic Resonance Imaging  
MRI is considered the ‘gold standard’ of body composition measures alongside CT. 
Through the use of multiple image slices a 3D model of volume can be estimated 
(Narici et al., 1992, Erskine et al., 2009), which can be used to measure bone 
(Woodhead et al., 2001), adipose tissue (Kullberg et al., 2009), skeletal muscle mass 
(Baumgartner et al., 1992, Narici et al., 1992) and connective tissue within the target 
area. MRI measurements are based on the high-water content, and hence proton 
content of body tissue. The magnetic field aligns the spin axis of the protons that is 
disturbed by radio frequency waves. Cessation of the wave leads to realignment of the 
proton spins, and the speed at which this realignment occurs is dependent on the 
position of the protons in the molecules. The receiver coils collect the radio frequency 
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waves emitted by the protons when spin orientation is manipulated. The differing 
frequencies received indicate the type of tissue: light grey being muscle, dark grey 
connective tissue and white adipose tissue.  
MRI as a modality is extremely accurate and reproducible and this is one of its main 
strengths. It can track small changes in mass over time as well as the ability to discern 
the individual muscles in a larger muscle group. MRI also does not emit radiation like 
CT or DXA scanning procedures, therefore making it an ideal candidate for repeated 
procedures in individuals. However, MRI machines and maintenance costs are high, 
and the scanning process and assessment of images takes skill and time, while some 
larger individuals may not be able to be scanner, all factors that lead to limited 
availability of this equipment. 
1.5 Mobility and Function measurements  
Six-minute walk test 
The assessment of functional capacity in terms of everyday living is essential for the 
diagnosis of functional limitation in the elderly and especially the frail elderly. While 
this can be done through self-reported measures, they carry the risk of over and under-
reporting. Therefore, more objective measures should be used, such as a shuttle walk 
test or 12-minute walk test. More commonly used is the 6-minute walk test (6MWT) 
(Enright, 2003) that is an inexpensive, valid measurement, with good levels of 
reproducibility (Pollentier et al., 2010, Costa et al., 2018). The 6MWT has also been 
reported to correlate with an individual’s peak oxygen uptake and is widely used to 
measure the response to therapeutic interventions (Enright, 2003).   
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Timed Up-and-Go 
The timed-up-and-go (TUG) test is a useful functional measure because it includes 
rising from a seated position, a short walk and negotiating a turn. Originally a ‘Get-Up 
and Go’ Test was developed (Mathias et al., 1986) to assess these factors of functional 
mobility, which was modified to enable an integrated measure of balance, gait speed 
and functional capacity (Podsiadlo and Richardson, 1991). This test has been found 
to be reproducible over time and between assessors, alongside fulfilling the criteria of 
a functional measurement (Solomon, 1988).   
Balance 
Nearly every neuromuscular disorder results in degeneration of balance control, with 
this loss of balance comes an increase in the chance of falls and in the elderly this 
often leads to death (Winter et al., 1990). It is important that individual’s neural control 
is able to handle many of the perturbations that occur during phases of locomotion 
and therefore improve fall outcomes in older individuals (Winter et al., 1990). Thus, 
the measurement of balance allows further assessment in the neuromuscular changes 
that occur during the ageing process.    
Muscle power 
The assessment of muscle power is most commonly measured through the counter 
movement jump, which can feedback data such as jump height, peak power, and peak 
velocity. Therefore, helping determine an individual’s neuromuscular status, the use 
of counter movement jump without arm swing has be shown to be a reliable 
performance measure when average values are taken (Claudino et al., 2017). Though 
it does appear that jumping mechanics do change with ageing, partly due to a 
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simultaneous coordination of muscle activation with advanced age (Haguenauer et al., 
2005).     
Isometric maximal voluntary contraction torque 
Isometric strength tests are those where a force is produced with the lengths of muscle 
remaining relatively fixed.  Lower limbs are usually assessed by asking an individual 
to push or pull against bar or cuff attached to a strain gauge. The use of such measures 
enables the assessment of maximal voluntary activation, giving insights into changes 
of maximal voluntary activation in such target populations (i.e. sarcopenic) (Bergamin 
et al., 2017, Nuzzo et al., 2018). It is important that such functional tests use best 
practice and are repeatable and reliable, isometric strength tests tend to be free of 
systematic bias and a have good test-retest reliability in healthy older adults (Bergamin 
et al., 2017, Nuzzo et al., 2018). The method used within this thesis to test contractile 
properties of human quadriceps longitudinally was shown to have excellent 
reproducibility (Appendix 1). 
Voluntary activation 
The use of electrical stimulation to assess human muscle contractile properties has 
been well established (Gerrits et al., 2001, Chan et al., 1999, Hunter et al., 1999, 
Degens et al., 2005, Morse et al., 2007b, Wust et al., 2008). To assess the voluntary 
activation an electrical evoked twitch is superimposed on the maximal voluntary 
contraction and the amount of extra force, when compared to an electrically-evoked 
twitch preceding the voluntary contraction, gives a measure of the degree of voluntary 
activation. 
Besides the assessment of voluntary activation, electrical stimulation allows the 
determination of muscle contractile indices such as the force frequency relationship, 
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fatigue resistance, maximum rate of contraction and relaxation while avoiding possible 
motivational bias. The contractile properties determined in this way appear to correlate 
with a variety of molecular or histochemical muscle features (Harridge et al., 1998).  
When performing repeated measures, it is important to know how reproducible the 
measurements are. This is particularly important when one wants to know the impact 
of an intervention on the contractile properties of the muscle, especially when one 
considers how muscle adapts to changes in functional demands (Baar and 
Hargreaves, 2011, Koopman and van Loon, 2009, Nuzzo et al., 2018).  
1.6 Longitudinal observations  
Large cross sectional studies which have been well-designed through the use of 
multiple methods of imaging, functional and questionnaire data, do provide sound 
measure of variability between young and old, that highlight a general downward trend 
in muscle mass (Mitchell et al., 2012). However, there is always the risk that systematic 
influences may skew the results, such as intergenerational differences for example, 
those born during rationing. Longitudinal studies overcome such systematic issues 
and are able to track estimates of muscle mass in the same population over a time, 
giving a more accurate and robust model of ageing. However, the current literature 
describing muscle mass changes longitudinally is limited, due to the inherent difficulty 
of collecting data over extended timescales.  
Frontera et al. (2000a) conducted a 12-year follow up study, using computed 
tomography, which alongside MRI is seen as the gold standard in body composition 
measurements. Thigh cross sectional area was calculated and then separated into 
anterior and posterior thigh muscles and the changes were reported for a small cohort 
(n=7, 65.4 ± 4.2 yr) of healthy sedentary men transitioning from their seventh decade 
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to eighth. A 1% annual decline in thigh CSA was reported, which outlined the 
accelerated loss of mass postulated to occur during this period, describing a larger 
loss than the estimated 0.5% annual decline reported by Maden-Wilkinson et al. 
(2014) in a cross sectional study of the same muscle group between young (early 
twenties) and old (early seventies) independent living adults. No differential rate of 
loss between extensor and flexor muscles was found, whereas an increased loss of 
extensor muscles compared to flexor muscle between young and old was reported by 
Maden-Wilkinson et al. (2014).  
Conversely, Hughes et al. (2002) reported losses of 0.2% in a larger sample size, 
describing individuals through their seventh decade, which is markedly lower than that 
reported by Frontera et al. (2000a) and even lower than reported in a cross-sectional 
study (Maden-Wilkinson et al., 2014). Similar losses were then reported by Dey et al. 
(2009) in an older cohort (75-80yrs) with an annual loss of 0.18%. Both of these studies 
reported changes in fat free mass, using hydro-densiometry and bioelectrical 
impedance to estimate the muscle changes. These methods may lack the sensitivity 
and specificity required to track changes in the muscle during ageing and therefore 
should be interpreted with caution.  
Larger-scale work as part of the Health, Ageing and Body Composition study was 
conducted. This work described the changes in much larger sample sizes, with 
Delmonico et al. (2009a) describing changes over a 5-year period using computed 
tomography and Koster et al. (2011) using DXA over a 7-year follow up in well-
functioning (reported no physical limitations and were not currently undergoing 
treatment for cancer) men and women during their eighth decade. The findings from 
Delmonico et al. (2009a) reported 0.98% annual thigh losses in men which is similar 
to the values published by Frontera et al. (2000a) which also used computed 
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tomography to assess muscle mass. However, Koster et al. (2011) found a lower 
annual loss of muscle mass over 7-years in men (0.8%), this may be due to differences 
in methodology. For example, previous work suggests an overestimation of muscle 
mass with the use of DXA (Maden-Wilkinson et al., 2013b, Visser et al., 1999, Levine 
et al., 2000, Shih et al., 2000). Men suffered from larger age-related loss of muscle 
mass than women in both the Health, Ageing and Body Composition reports (Koster 
et al., 2011, Delmonico et al., 2009a), with women reporting an annual decline of 
0.64% (Delmonico et al., 2009a) and 0.7% (Koster et al., 2011). Suggesting there is 
disparity between how men and women age which has also been suggested in other 
studies (Iannuzzi-Sucich et al., 2002, Castillo et al., 2003, Janssen et al., 2000c).  
Of the longitudinal studies conducted currently, both Koster et al. (2011) and 
Delmonico et al. (2009a) represent the most reliable data in free-living older adults, 
though these still lack the detail to fully characterise age-related loss in muscle mass.  
1.7 Summary of current research 
The majority of our knowledge of effects of old age on musculoskeletal structure and 
function come from cross-sectional studies that compared data from young with data 
from older adults to try to understand mechanisms behind the decrease in muscle 
mass with ageing and the larger proportional loss of function. However, there is always 
the potential bias related to differences in genotype and changes in life-style over the 
decades that human ageing takes that may cause unintended bias in cross-sectional 
studies. Such bias can be overcome in longitudinal studies of changes in muscle size 
and function with ageing. Such studies are the minority, often only covering relatively 
simple assessments that can be carried out easily and cost effectively as part of large 
epidemiological studies or health assessments. They have not had an integrated 
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approach of structural and functional changes in skeletal muscle and their impact on 
the ability to perform activities of daily life. Which can only be achieved with multiple 
validated testing procedures on a cohort. In addition, many studies investigating the 
impact of ageing on muscle mass have used DXA with little consideration of the 
possible over- or underestimation of muscle mass by this technique. It is therefore key 
that these factors are uncovered and described in detail to give a clearer view of 
ageing into the eighth decade, especially as humans are now living longer though 
towards the end of their lifespan not necessarily in good health. The maintenance of 
mobility and health into old age a key current challenge, with the development of 
mobility impairments of leading to a decrease in quality of life. Consequently bringing 
to the forefront and encouraging the implementation of interventions that can attenuate 
such changes. 
1.7 Unresolved issues 
There are still a number of unresolved issues when it comes to muscle ageing: 
- Whether DXA measurements are appropriate and accurate to track 
changes in muscle mass longitudinally in older adults.  
- What the underlying causes of the increased proportional loss of force is 
ageing  
- Whether there is an accelerated decline in muscle mass seen in healthy free 
living septuagenarians during later ageing, compared to the linear decline 
described in cross sectional studies  
- How functional capacity in healthy individuals entering their 8th decade 
alters, in comparison to relative changes seen over prior decades 
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1.8 Aim of the Thesis  
The overall aim of the work in this thesis was to track and characterise longitudinal 
changes in muscle size and function and how this impacts on the ability to perform 
activities of daily life over a 5-year period, in healthy free-living septuagenarians. 
Which is of particular interest and importance due to the increasing proportion of the 
population over 60 years of age. It is estimated this population will more than triple 
within 50 years to over 2 billion by 2050 (WHO, 2018). The participants in this work 
were part of a larger European-wide cross-sectional study (MYO AGE) to describe the 
aforementioned characteristics. The objectives of the work presented in this thesis 
were: 
1) To assess the reliability of DXA measurements against MRI to assess longitudinal 
changes in muscle mass in older populations. 
2) To uncover the gross functional basis of the age-related changes in mobility seen 
in older individuals. 
3) To describe the influence of fibre atrophy, fibre loss, in situ specific force, and 
voluntary activation to muscle weakness seen with ageing.  
 
The following work presents novel data to address each of the above objectives. 
 
This work was proceeded by a larger project known as “Myoage” (nr: 223576), funded 
from the European Commission, alongside the Medical Research Council as part of 
the Life Long Health and Wellbeing initiative (MR/K/025252/1) and is entirely the work 
of James Cameron.  
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Chapter 2 
 
 
Five-year longitudinal changes in thigh muscle mass of 
septuagenarian men and women assessed with both DXA and MRI 
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2.1 Abstract 
Magnetic resonance imaging (MRI) and dual-energy absorptiometry (DXA) were used 
to assess changes in thigh lean mass in septuagenarian men and women during a 5-
year longitudinal study. Twenty-four older individuals participated in the study (10 men; 
71.6±4.1 y: 14 women; 71.3±3.2 y at baseline). Thigh MRI and whole-body DXA scans 
were used to estimate changes in thigh lean mass. Both MRI and DXA showed that 
thigh lean mass was reduced by approximately 5% over the 5-year period in both men 
and women (P=0.001).The percentage loss of muscle mass determined with MRI and 
DXA showed moderate correlation (R²=0.466; p<0.001). However, DXA over-
estimated thigh lean mass at both baseline and follow-up by 0.86 and 0.82 kg, 
respectively. Bland Altman analysis showed that the average atrophy over five years 
of follow-up measured by DXA was only 0.18% greater than MRI, where the limits of 
agreement between DXA and MRI were ±10.4%. Baseline thigh lean mass did not 
predict the percentage loss of thigh lean mass over the 5-year period (R²=0.003; 
P=0.397), but a higher baseline body fat percentage was associated with a larger loss 
of thigh muscle mass in men (R²=0.677; P<0.003) but not women (R²=0.073; 
P<0.176). In conclusion, 1) DXA and MRI showed a similar percentage loss of muscle 
mass over a 5-year period in septuagenarian men and women that 2) was independent 
of baseline muscle mass, but 3) increased with higher baseline body fat content in 
men. 
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2.2 Introduction 
Ageing is accompanied by changes in muscle mass that are thought to contribute to 
reduced physical function and vigour, and the eventual loss of independence in old 
age (Doherty, 2003a). This loss of  muscle mass and physical function has been 
described as sarcopenia (Rosenberg, 1989b). By the 8th decade, muscle mass has 
declined by around 30% from peak values, with these losses principally coming from 
the atrophy of type II fibres (Barnouin et al., 2017b) and loss of muscle fibres (McPhee 
et al., 2018). The loss of myofibers seen in ageing is thought to be a consequence of 
motor neuron death and it has been reported that up to 50% of motor units are lost by 
the 8th decade (Piasecki et al., 2018a). It should also be noted that there might be a 
differential rate of age-related loss of muscle mass between men and women, with 
men thought to suffer to a greater degree (Iannuzzi-Sucich et al., 2002, Castillo et al., 
2003, Janssen et al., 2000c). With increased adipose tissue also thought play a role 
in the rate of age-related loss of muscle mass (Newman et al., 2003). 
The major problem with most studies of human ageing is that they are cross-sectional 
and it is important to develop and validate methods to assess changes in muscle bulk 
in longitudinal studies. Muscle imaging techniques allow the non-invasive evaluation 
of skeletal muscle size and architecture (Lee et al., 2013) and include bio-electrical 
impedance (BIA), CT, DXA and MRI (Heymsfield et al., 1990, Narici et al., 1992, Wang 
et al., 1996, Visser et al., 1999). CT and MRI are generally considered the gold 
standard, allowing the accurate assessment of muscle cross-sectional area, muscle 
mass and intramuscular adipose tissue content. Nonetheless, these techniques are 
expensive and consequently DXA (Baumgartner et al., 1998) and BIA (Janssen et al., 
2000a) are frequently used to identify sarcopenia.  
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Previously, good correlations have been found between muscle size estimations with 
CT, DXA and MRI in similar groups of individuals (Fuller et al., 1999, Visser et al., 
1999, Levine et al., 2000, Segal et al., 2009, Maden-Wilkinson et al., 2013b). However, 
despite a strong correlation (R²=0.90 young, R²=0.83 old) in a large cross-sectional 
cohort study, thigh muscle mass was over-estimated by DXA as the slope of the DXA-
MRI relationship was steeper than 1 and had an intercept of approximately 0.4 kg 
(Maden-Wilkinson et al., 2013b). In addition, DXA underestimated the percentage 
difference in muscle mass between young-adults and older people (Maden-Wilkinson 
et al., 2013b), suggesting that DXA underestimates the age-related loss of muscle 
mass. It remains to be seen, however, whether longitudinal changes in skeletal muscle 
mass of older people can indeed be determined with DXA, or that this method also 
underestimates the loss of muscle mass beyond the age of 70 as a consequence of 
the increased fraction of the intercept of the whole signal. 
Therefore, the purpose of the present study was to compare changes in muscle bulk 
as measured by DXA and MRI in a 5-year longitudinal study of men and women in 
their 8th decade. It was hypothesised that DXA underestimates the loss of muscle 
mass when compared with MRI. In addition, we studied whether the rate of muscle 
loss is 1) negatively related to baseline muscle mass and/or 2) positively related to 
baseline body fatness. 
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2.3 Methods  
Participants and ethical approval 
The participants are a subgroup from the cross-sectional MYOAGE study 
(www.myoage.eu) (McPhee et al., 2013). The participants were recruited from the 
local community (Manchester, UK) and were asked 5 years later to return for a follow-
up study. Data presented in this report are from the twenty-four older participants that 
returned (10 men, 14 women), with a drop-out rate of 74% from the original cohort of 
66 men and women. Written informed consent was obtained from each participant 
before partaking in both the first and the follow-up study. The studies conformed to the 
Declaration of Helsinki and were approved by the local ethics committee of the 
Manchester Metropolitan University. Participant characteristics are presented in Table 
2.1. All individuals were community dwelling, socially active and classed as healthy. 
Exclusion criteria were: known musculoskeletal or cardiovascular diseases, any limb 
fractures within 5 years of testing, hip or knee replacement in the previous 2 years, 
immobilised for greater than 1 week 3 months prior to testing, institutionalisation, 
unable to walk 250 m unassisted, chronic pain syndrome, metabolic disease, chronic 
obstructive pulmonary disease, or neurological disorders (e.g. Parkinson’s).  
Anthropometry 
While wearing light indoor clothing, body mass was recorded on a digital scale to the 
nearest 0.1 kg. Standing height was measured using a stadiometer to the nearest 1 
mm. Body mass index (BMI) was calculated as body mass (kg)/(height (m)²).   
Duel Energy X-ray absorptiometry  
Participants lay supine on the scanning bed wearing a medical gown. A total body 
DXA (Lunar Prodigy Advance, GE Healthcare, Chicago, USA) scan was performed to 
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measure total body composition and bone mineral density. Estimations of total lean 
mass and fat mass were obtained using Prodigy, Encore 2006 v10.50.086 software 
(GE Healthcare). To estimate the fat mass, bone mineral content and lean mass in the 
thigh of the dominant leg, the thigh was demarcated by one border proximally and 
parallel to the greater trochanter and another through the knee joint line, as described 
previously (Segal et al., 2009, Maden-Wilkinson et al., 2013b) (Fig. 2.1A). All DXA 
analyses were completed by the same investigator. Each standard total body scan 
took 295 s with an estimated skin entrance dose of 0.4 µGy (GE Healthcare, Lunar 
encore, Safety and Specification Manual). Typically, the estimates of lean mass by 
DXA software packages include connective tissue, non-mineral components of bone 
and non-adipose components of fat tissue alongside muscle mass. As the contribution 
of these factors is unclear and possible changes of these components with aging 
unknown, we did not correct for these potential confounders. The system was 
calibrated with the same whole-body phantom at baseline and at 5 years follow up 
before each scan. 
Magnetic Resonance Imaging  
In six of the participants, thigh volume was measured using a 0.25-T MRI scanner (G-
Scan, Esaote, Genova, Italy). The participant was in a supine position in the scanner 
and multiple 3.1 mm thick serial transverse sections were acquired every 25 mm from 
the proximal to the distal heads of the femur of the dominant leg using a turbo 3D T1-
weighted protocol (matrix 256 x 256, TR 40 ms, TE 16 ms). The cross-sectional area 
of the four quadriceps muscles and other thigh muscles (hamstrings, abductors and 
adductors) in each slice (Fig. 2.1B) were determined using computer imaging software 
(OsiriX medical imaging software, OsiriX, Atlanta, USA). Visible fat and connective 
tissue were not included in the measurement region, with all muscles measured three 
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times with the average recorded. Estimated total thigh volume was calculated through 
the summation of the cross-sectional area of each head of the individual quadriceps 
muscles and other muscles in each slice, multiplied by the distance between slices. It 
was not possible to measure the rectus femoris (RF) beyond the head of the femur, 
due to limitations of coil size. Therefore RF volume for the proximal 10% was 
calculated assuming conical volume from the last transverse section to the origin of 
the muscle, identified using ultrasound (Esformes et al., 2002). MRI volumes were 
converted to mass by multiplying by the density of muscle tissue 1.04 g.cm-3 (Snyder 
et al., 1975), aiding the comparison between measures. It has previously been shown 
that thigh muscle volume can be calculated from a single scan (Morse et al., 2007a, 
McPhee et al., 2009). In a subset of  six subjects, a good correlation was found 
between the measured and the calculated thigh muscle volume (R² = 0.89; p=0.007) 
also in this cohort. Consequently, in the remaining 18 participants, thigh volume was 
estimated from a single scan taken at 60% of the length from distal-to-proximal femur 
(Morse et al., 2007a). 
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Figure 2.1. (A) Example of dual energy X-ray absorptiometry (DXA) image showing regions of interest 
of the thigh. (B) Magnetic resonance imaging (MRI) image of the thigh muscles. VI: vastus intermedius; 
VL: vastus lateralis; VM: vastus medialis; RF: rectus femoris; OM: other muscles. 
 
Statistics 
Data were analysed using SPSS v22 (IBM, 2015). Repeated-measures ANOVA with 
“within subject factor” time (baseline and follow-up) and “between subject factor” 
gender was used. A gender*time interaction indicated that men and women changed 
differently over time. Linear regression analysis was conducted to consider 
correlations between measurements. Statistical significance was accepted as p<0.05. 
Data were expressed as mean ± standard deviation unless stated otherwise. Bland 
Altman analysis (Bland and Altman, 1999) was used to determine the limits of 
agreement between DXA and MRI.  The test-retest variability was given as the 
A BA
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coefficient of variation (CVp), which was calculated as the SD of the differences 
between MRI and DXA as a proportion of the mean: CVp = √((∑CVᵢ²)/n). 
 
2.4 Results 
Participant Characteristics  
Women were shorter, had lower FFM, appendicular lean mass (ALM), and  bone 
mineral density (BMD) than men (Table 2.1; p<0.001). The participants lost about 1 
cm in stature over the 5-year period as well as having lower FFM and ALM (p≤0.001), 
irrespective of gender. The gender*time interactions for body mass (p=0.029) and BMI 
(p=0.019) were reflected by a decrease in body mass and BMI in women, but not in 
men. There was no significant change in Fat mass and BMD over the 5-year period. 
Table 2.1. Participant characteristics 
  Women  (n=14)   Men        (n=10)   Significant differences  
  Baseline Follow-up % change Baseline Follow-up % change Time  Gender Gender*Time 
Age (years) 71.3±3.2 76.2±3.3   71.6±4.1 76.2±4.4   P=0.000 P=0.923 P=0.193 
Body mass (kg) 65.5±10.4 63.4±10.9 -3.5 83.6±15.2 83.9±15.1 0.5 P=0.079 P=0.000 P=0.029 
Height (m) 1.61±0.07 1.60±0.06 -0.5 1.74±0.08 1.73±0.08 -0.5 P=0.000 P=0.000 P=0.874 
BMI (kg/m²) 25.6±5.47 25.0±5.5 -2.0 27.7±4.4 28.1±4.1 1.5 P=0.798 P=0.123 P=0.019 
FFM (kg) 39.0±3.1 37.7±3.1 -3.5 55.3±8.1 54.5±7.5 -1.5 P=0.001 P=0.000 P=0.378 
FM (kg) 24.1±9.4 23.5±10.3 2.5 25.0±10.4 26.1±10.3 4.5 P=0.580 P=0.604 P=0.075 
FM (%) 37.0±9.2 36.9±9.94 0 30.2±9.2 31.5±8.7 4.5 P=0.236 P=0.056 P=0.172 
ALM (kg) 17.4±1.8 16.7±1.75 -4.0 25.7±4.0 24.6±3.7 -5 P=0.000 P=0.000 P=0.206 
BMD (g/mm²) 1.07±0.10 1.07±0.10 0 1.25±0.12 1.26±0.12 1.0 P=0.352 P=0.000 P=0.519 
 
Data shown as mean ± SD. Abbreviations: BMI: Body Mass Index; FFM: Fat Free Mass; FM: Fat Mass; ALM: Appendicular Lean 
Mass; BMD: Bone Mineral Density.  
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Correlations between MRI and DXA 
 
Figure 2.2. (A) The relationship between thigh lean mass as determined by DXA vs as determined by 
MRI. ■: men and ●: women at baseline, and □: men and ○: women at follow-up. ---: line of identity; ---: 
regression line at baseline; ···: regression line at follow-up. Equations – left: baseline; right: follow-up. 
(B) Bland-Altman plot to show the absolute agreement between MRI and DXA; ■: men and □: women. 
Horizontal dashed lines represent 1.96 standard deviation above and below the average difference 
between methods, depicting levels of agreement (+0.54 kg upper level of agreement and -0.37 kg lower 
level of agreement). Solid horizontal line represents the bias between methods (DXA shows a 0.09 kg 
larger loss of muscle mass than MRI over the 5-year period). 
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Both MRI and DXA showed that men had larger muscles than women (Table 2.2; 
p≤0.001). Figure 2.2A shows the correlation between thigh muscle size as measured 
by DXA and MRI for values at baseline (R²=0.857; p<0.001) and at the 5-year follow-
up (follow-up R²=0.818; p<0.001). The regression lines of the two correlations were 
very similar.  
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Figure 2.3. (A) The relationship in men and women between thigh lean mass percentage change as 
determined by DXA vs MRI. ■: men and □: women; ---: line of identity; -·-: regression. (B) Bland-Altman 
plot to show the percentage agreement between MRI and DXA. ■: men and □: women. Horizontal 
dashed lines represent 1.96 standard deviation above and below the average difference between 
methods, depicting levels of agreement (+10.2% upper level of agreement and -10.6% lower level of 
agreement). Solid horizontal line signifies the 0.18% larger decrease in muscle size determined by DXA 
than by MRI. 
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When analysing data showing the changes to muscle size over the 5-year follow-up, 
Bland Altman plots (Fig. 2.2B) showed a 0.09 kg larger loss measured by DXA 
compared with that measured by MRI. Limits of agreement between DXA and MRI 
was ±0.453 kg. The percentage loss of muscle mass determined with MRI and DXA 
showed moderate correlation (R²=0.466; p<0.001; Fig. 2.3A). Bland Altman plots (Fig. 
2.3B) show a 0.18% lower muscle loss measured by MRI compared with DXA and the 
limits of agreement between DXA and MRI was ±10.4%. The overall pooled co-
efficient of variation (pCV) between MRI and DXA over 5 years was 0.045%. 
Longitudinal changes in thigh lean mass 
Table 2.2. Measurements of thigh muscle size by dual energy X-ray absorptiometry (DXA) and 
magnetic resonance imaging (MRI). 
            
   Women (n=14) Men (n=10) Significant differences   
   Baseline Follow-up % change Baseline Follow-up % change Time  Gender Gender*Time  
 
MRI Quadriceps muscle 
lean mass (kg)  1.05±0.16 1.01±0.16 -4.5 1.63±0.31 1.48±0.28 -8.8 P=0.001 P=0.001 P=0.61  
 
MRI Other muscle lean 
mass (kg) 1.39±0.15 1.30±0.18 -6.4 1.94±0.34 1.86±0.35 -3.8 P=0.001 P=0.001 P=0.756  
 
Quadriceps:other muscle 
ratio 0.76±0.08 0.78±0.11 0.00 0.85±0.15 0.81±0.13 -0.05 P=0.517 P=0.224 P=0.078  
 
MRI Total thigh lean mass 
(kg) 2.44±0.29 2.31±0.31 -5.5 3.56±0.57 3.35±0.57 -6.1 P=0.001 P=0.001 P=0.228  
 DXA Thigh lean mass (kg) 3.89±0.36 3.59±0.40 -8.0 5.55±0.98 5.34±0.93 -4.0 P=0.001 P=0.001 P=0.529  
 MRI:DXA (ratio) 0.65±0.07 0.67±0.06 2.48 0.67±0.07 0.66±0.09 -2.32 P=0.967 P=0.904 P=0.039  
            
Data shown as mean ± SD. 
 
MRI showed a similar percentage decrease in thigh muscle size in men and women 
(Table 2.2). The percentage rate of loss of thigh lean mass did not differ significantly 
between DXA and MRI (p=0.841), as indicated by similar MRI:DXA ratios (Table 2.2) 
for thigh muscle size at baseline and 5-year follow up (p=0.967). 
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It is possible to distinguish the quadriceps and other muscles in the thigh with MRI to 
investigate possible differential atrophy between thigh muscles. The ratio of 
quadriceps to other muscles was similar in both genders at baseline (Table 2.2; 
p=0.224) and the absence of a significant age-related change in this ratio (Table 2.2; 
p=0.517) indicated that the atrophy was similar in both muscle compartments. 
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Figure 2.4. (A) The association between baseline thigh muscle volume and % change of thigh muscle 
volume at follow up in magnetic resonance imaging (MRI) (B) Association between baseline thigh 
muscle volume and % change of thigh muscle volume at follow up in dual energy X-ray absorptiometry 
(DXA). ■: men and □: women; ---: regression line.  
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Figure 2.5. (A) Baseline body fat % association with the percentage change in muscle volume on follow 
up, as measured by magnetic resonance imaging (MRI) and (B) dual energy X-ray absorptiometry 
(DXA). ■: men and □: women; -- regression line men; -·- regression line women; Equations – left: men; 
right: women.   
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There was no significant correlation between baseline thigh muscle volume and the 
percentage decline over the 5-year period in either men or women when measured by 
either MRI (Fig. 2.4A; R²=0.003; p=0.397) or DXA (Fig. 2.4B; DXA: R²=0.009; 
p=0.326). However, baseline body fat percentage was associated with a larger 
percentage decrease in muscle volume following the 5-year period in men (Fig 2.5A 
MRI: R²=0.677; p=0.003; Fig 2.5B DXA: R²=0.308; p=0.048), but not in women (Fig 
2.5A MRI: R²=0.073; p=0.176; Fig 2.5B DXA: R²=0.024; p=0.298). 
2.5 Discussion 
It has previously shown that DXA provides higher values for thigh muscle mass than 
MRI measurements and that, when comparing young and old, MRI measurements 
suggest a greater age-related decline in muscle mass than that obtained from DXA 
measurements (Maden-Wilkinson et al., 2013b). DXA is a convenient method to 
assess body composition and muscle mass but our previous cross-sectional 
observations raised concerns about its suitability for use in longitudinal studies of 
changes in muscle mass and progression of sarcopenia. In the present study it was 
confirmed that DXA gives higher values for thigh muscle mass than MRI and this was 
extended to show that the percentage loss of muscle mass over a 5-year period was 
similar for DXA and MRI.  We also showed that the percentage loss of muscle mass 
in the 5-year period was similar in 1) quadriceps and hamstring muscles, 2) 
recreationally active healthy older men and women, 3) was independent of baseline 
muscle mass, 4) was greater in men with a higher baseline body fat percentage, and 
5) that the rate of muscle decline was higher than that estimated from cross-sectional 
comparisons of people aged in their 20s compared with those in their 70s. 
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DXA vs. MRI 
MRI total volume measurements are widely regarded as the gold standard though 
these measurements are both time consuming and costly. The cost and time can be 
reduced significantly by calculating muscle volume from a single MRI scan. Here we 
show that this is not only possible in young men (Morse et al., 2007a) and older men 
and women (Maden-Wilkinson et al., 2014), but that even the percentage decrease in 
thigh muscle cross-sectional area over a 5-year period correlated strongly with the 
percentage decrease in thigh muscle volume (y=1.03x–0.04; R²=0.875; p=0.003). This 
indicates that estimating changes in muscle size from single MRI transverse sections 
taken at 60% of femur length is sufficient to assess changes in muscle volume 
longitudinally. 
While the use of a single MRI scan already saves considerable time, and hence cost, 
MRI and CT are not commonly available. DXA has become a popular modality to 
assess body composition and muscle mass in large cohort studies, due to its wider 
availability and ease of use (Ellis, 2000, Visser et al., 2003, Goodpaster et al., 2006, 
Zhong et al., 2012, Santanasto et al., 2017). Although a good correlation was found 
between the thigh muscle mass determined by DXA and MRI in both men and women 
at both baseline and follow-up, DXA consistently overestimated the muscle mass due 
to a positive intercept and a slope of the regression line greater than 1. Such a positive 
intercept has been seen before in young adults and older people (Visser et al., 1999, 
Levine et al., 2000, Shih et al., 2000). This is also in line with previous work shown in 
a large cohort study reporting a positive intercept and a slope steeper than 1 (Maden-
Wilkinson et al., 2013b). It has been suggested that protein or other material in adipose 
tissue may contribute to this over estimation of muscle mass by DXA (Abe et al., 2015, 
Loenneke et al., 2016). However, in our previous study, adjustments to account for 
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connective tissue, fat infiltration and none-bone mineral content of bones (Heymsfield 
et al., 1990, Kent-Braun et al., 2000) did not remove this bias. 
In practice, and when following changes over a relatively short time scale of 5 years, 
the difference between the two methods (MRI and DXA) is small. Bland Altman 
analysis showed a discrepancy between the change in muscle mass as determined 
by MRI and DXA in absolute terms of 0.09 kg and in percentage terms of 0.18% over 
the 5-year period. This suggests that DXA is an acceptable method for longitudinal 
tracking of muscle mass in older people. 
Longitudinal age-related decline in muscle mass in older people 
Ageing is associated with an overall reduction in skeletal muscle mass that contributes 
significantly to the loss of muscle strength (McPhee et al., 2018). This loss of strength 
and concomitant slowing of the muscle (Simunic et al., 2018) result in an age-related 
reduction in muscle power that is associated with a reduced performance in the timed-
up-and-go and 6-minute-walking test (Maden-Wilkinson et al., 2015). As the proportion 
of older people is rising in the western world, it is important to understand sarcopenia 
and its progression towards frailty in the older person (McPhee et al., 2016). Here, we 
found with both DXA and MRI that over the relatively short time period of 5 years, 
muscle mass decreases by ~5% in people in their seventies. This is relatively more 
than the 25% lower muscle mass seen in a cross-sectional comparison of 
recreationally active people in their seventies and their 50 years younger counterparts 
in their twenties (Maden-Wilkinson et al., 2014). It indicates that the age-related rate 
of muscle decline is possibly accelerated during the eighth decade of human ageing  
(Degens and Korhonen, 2012, Ganse et al., 2018), and/or that the rate of loss of 
muscle mass before age 70 only starts beyond e.g. the age of 45 (Janssen et al., 
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2000c). Thus halving the period of atrophy between the twenties and seventies. It is 
important that we are able to distinguish the differing phases of ageing, so we are able 
to describe changes in the loss of muscle mass seen at various points during the 
human lifespan.  
Some studies report that the age-related loss of muscle mass is larger in men than in 
women (Iannuzzi-Sucich et al., 2002, Castillo et al., 2003, Janssen et al., 2000c), while 
others show similar losses for both genders (Janssen et al., 2002). Part of the 
discrepancy may be due to the way changes in muscle mass are reported. In absolute 
terms men lose more mass than women because men have a larger muscle mass to 
start with, but in percentage terms the decrease is similar for men and women, as we 
observed in the present 5-year longitudinal study. In line with this, we found that while 
baseline muscle mass was, if anything, associated with a larger loss of muscle mass, 
it did not correlate with the percentage age-related decline in muscle mass. It has been 
reported that a lower muscle mass is associated with functional impairment and 
physical disability (Janssen et al., 2002). Though in absolute terms, as there was no 
difference in the relative rate, the decrease in muscle mass occurs at a faster rate in 
those with larger muscles, they will reach the disability threshold later, illustrating that 
it is in the long run beneficial to have a larger muscle mass (Degens, 2018, Degens 
and McPhee, 2013)  
Previous cross-sectional studies have shown that increased levels of adipose tissue 
may accelerate the age-related loss of muscle mass and strength in both men and 
women (Newman et al., 2003, Koster et al., 2011, Tomlinson et al., 2014, de Carvalho 
et al., 2018). In the present study the percentage muscle loss over 5 years was 
positively related to the percentage body fat in men, but this was not the case for 
women. Particularly visceral fat mass is an important source of inflammatory cytokines 
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(Pedersen, 2009) and an increase in the fat mass is likely to contribute to chronic low-
grade systemic inflammation in older people that can cause muscle wasting and 
dysfunction (Degens, 2010). With visceral fat being shown to accelerate the loss of 
muscle mass in older individuals in particular (Kim et al., 2014). These observations 
stress the benefit of a low body fat percentage for skeletal muscle health in old age 
and hence the importance of a healthy diet and regular physical activity (McPhee et 
al., 2016, Mithal et al., 2013).  
Previously, it has been observed in a cross-sectional study that there appears to be a 
differential rate of atrophy between extensors and flexors seen in ageing, with the 
quadriceps muscles declining by 30% and the other muscles in the thigh only declining 
18% in older people in their seventies, compared to young-adults in their twenties 
(Maden-Wilkinson et al., 2013b). Here we did not see a differential rate in loss of 
muscle mass over the 5-year period. It remains to be seen whether there is indeed a 
differential rate of atrophy in these muscles during early ageing, followed by a similar 
rate of age-related atrophy in old age. 
Conclusion 
Both DXA and MRI showed a similar percentage atrophy over a 5-year period in 
septuagenarians. The rate of atrophy was independent of the muscle mass at baseline 
and similar for men and women. A high percentage body fat was, however, associated 
with a faster rate of muscle decline in men. These data indicate that 1) DXA can be 
used to assess longitudinal changes in muscle mass in older people, 2) a 
proportionally larger decline of muscle mass than the 25% difference between people 
in their twenties and seventies (Maden-Wilkinson et al., 2013b), 3) a low muscle mass 
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is not indicative of a higher rate of age-related muscle wasting and 4) increased body 
fatness was associated with an greater rate of age-related muscle loss in men. 
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Chapter 3 
 
 
The Contributions of Fibre Atrophy, Fibre Loss, In Situ Specific 
Force, and Voluntary Activation to Weakness in Sarcopenia 
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3.1 Abstract 
The contributions of fibre atrophy, fibre loss, in situ specific force and voluntary 
activation to weakness in sarcopenia remain unclear. To investigate, forty older (20 
women; age 72±4yrs) and 31 younger adults (15 women, age 22±3yrs) completed 
measurements. The knee extensor maximal voluntary torque (MVC) was measured 
as well as voluntary activation, patella tendon moment arm length, muscle volume and 
fascicle architecture to estimate in situ specific force. Fibre cross-sectional area 
(FCSA), fibre numbers and connective tissue contents were also estimated from 
vastus lateralis biopsies. The MVC, quadriceps volume and specific force were 39%, 
28% and 17% lower, respectively, in old compared with young, but voluntary activation 
was not different. The difference in muscle size was due in almost equal proportions 
to lower type II FCSA and fewer fibres. Five years later (n=23) the MVC, muscle 
volume and voluntary activation in old decreased an additional 12%, 6% and 4%, 
respectively, but there was no further change in specific force. Conclusions: in situ 
specific force declines relatively early in older age and reduced voluntary activation 
occurs later, but the overall weakness in sarcopenia is mainly related to loss of both 
type I and II fibres and type II fibre atrophy. 
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3.2 Introduction 
Skeletal muscle weakness is a key feature of sarcopenia (Cruz-Jentoft et al., 2019)  
and a core component of the physical frailty phenotype (Fried et al., 2001). Weakness 
increases the effort required to complete everyday physical tasks and is associated 
with a higher risk of falling, disability, hospital admission and mortality (Clark and 
Manini, 2010). To develop effective countermeasures, it is important to understand the 
factors contributing to weakness. 
In young adults, a close relationship exists between muscle cross-sectional area and 
the maximal force produced by that muscle (Bamman et al., 2000, Maughan et al., 
1983). During ageing the muscle mass declines in part due to type II fibre atrophy 
(Andersen, 2003, Barnouin et al., 2017a), which contributes to muscle weakness. 
Fibre losses may also contribute to low muscle mass, although there is surprisingly 
little data on this matter and conflicting reports with one suggesting fibres are lost with 
ageing (Lexell et al., 1988) and another stating they are not (Nilwik et al., 2013). 
Irrespective of the reasons why muscle mass declines, recent reports argue that the 
relationship between muscle mass and maximal force is weak in older adults 
(Senechal et al., 2015, Clark and Manini, 2008). This viewpoint is based on the 
apparent disparity in the age-related changes of maximal force and lean mass seen in 
cross-sectional studies (Chen et al., 2013, Lynch et al., 1999) and longitudinal studies 
where a three-fold greater decline of maximal force compared to appendicular lean 
mass has been reported (e.g. (Goodpaster et al., 2006, Hughes et al., 2001a)). It might 
be concluded, therefore, that low muscle mass is not the primary cause of weakness 
in older age and this has led to interest in possible changes in “muscle quality”, 
measured as maximal force per unit muscle mass (e.g. see (Goodpaster et al., 2006, 
McGregor et al., 2014, Hairi et al., 2010b, Lynch et al., 1999, Moore et al., 2014)). 
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However, this literature has two important limitations. First, it is strongly influenced by 
studies using DXA to estimate the muscle size. Additionally, previous work did not 
consider potentially important physiological and anatomical contributions to force 
production, including activation of the motor unit pool, muscle architecture and joint 
structures. 
To understand the causes of weakness in older age, it is necessary to take account of 
several factors. First, the maximal muscle force depends on all available motor units 
of the agonist muscles being fully activated (Clark and Taylor, 2011). Secondly, 
muscle force is proportional to the number of fibres (or, sarcomeres) in parallel, 
represented by the physiological cross-sectional area (PCSA), rather than the 
anatomical cross-sectional area (CSA), of the agonist muscles (Degens et al., 2009b). 
Thirdly, muscle and joint architecture influence the external torque because the tendon 
force decreases in proportion to the cosine of the fibre pennation angle, while external 
torque increases proportionately with the tendon moment arm (Degens et al., 2009b). 
Considering all of these factors together gives a better estimate of muscle quality than 
just normalising maximal force to lean mass derived from DXA, and is referred to here 
as in situ specific force. Previous studies showed lower in situ specific force of plantar 
flexors (Morse et al., 2005b) and voluntary activation of knee extensors (Clark and 
Taylor, 2011) in old compared with young. However, there is currently limited 
information about specific force and voluntary activation of sarcopenic muscle and no 
information about longitudinal changes in specific force for older adults. 
The aim of the present study was to estimate the contributions of muscle size and 
specific force to the maximal external muscle torque in young and older adults. The 
hypothesis was that low muscle mass as well as reduced voluntary activation and in 
situ specific force contribute to weakness in sarcopenia. Following on from this, we 
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aimed to estimate the contributions of muscle fibre atrophy and muscle fibre loss to 
the overall quadriceps muscle atrophy with ageing. These aims were addressed 
through comparison of results from young and older adults and a longitudinal 
examination of older adults. 
3.3 Methods 
Ethical approval and research participants 
The Local Research Ethics Committee approved the study. All volunteers provided 
written informed consent. Volunteers were excluded if they were involved in any 
competitive sports (recreational sports were allowed) or had cardiovascular (controlled 
hypertension was allowed), metabolic, musculoskeletal, neurological or mental 
conditions, or body mass index <18 or >32 kg·m-2.  
Participants arrived at the research facility between 9am and 10am. DXA and MRI 
images were collected, followed by the grip strength, timed-up-and-go and 6-minute 
walk tests. A light snack and drink were provided and after a 30 minute break, the 
assessments of knee extensor voluntary activation and architecture were completed. 
For longitudinal studies, the older participants were invited to complete the same 
assessments 5 years later. Participant characteristics are shown in Table 1, including 
results for the basic functional assessments of 6 minute walk test (walking as far as 
possible in 6 min around cones placed 20 m apart), maximal grip strength (Jamar 
dynamometer performed twice on each hand and the maximum value taken) and 
timed up and go (TUG: starting from a seated position, stand and walk around a cone 
placed 3 m in front and then return to the original seated position), which were all 
performed following standardised procedures described previously (McPhee et al., 
2013). 
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Musculoskeletal imaging 
Participants were scanned by DXA (Lunar prodigy advance, GE Healthcare, Chalfont 
St Giles, UK) after an overnight fast in the supine position whilst wearing a light cotton 
robe. Off-line analysis (encore 2006 v 10.50.086) identified whole body lean mass and 
body fat percentage, arm and leg lean mass and bone mineral content (McPhee et al., 
2013). ALM was calculated as: [(lean mass of legs + lean mass of arms) – (bone 
mineral content of legs + bone mineral content of arms)] (Goodpaster et al., 2006). 
A 0.25-T MRI scanner (G-scan, Esaote Biomedica, Genoa, Italy) was used to collect 
transverse plane sections (Turbo-3D T1-weighted protocol with consecutive 2.8 mm 
thick slices) from the dominant leg tibial tubercle through to the anterior-inferior iliac 
spine with participants in the supine position (Maden-Wilkinson et al., 2013a). Osirix 
imaging software was used to estimate the anatomical cross-sectional areas of each 
of the four heads of the quadriceps muscles from transverse-plane images at 25 mm 
intervals from the distal to the proximal ends of the quadriceps. These cross-sectional 
areas were summed and multiplied by the distance between slices (2.5 cm) to estimate 
quadriceps muscle volume. The patella tendon moment arm was imaged with the leg 
at full extension and estimated from sagittal-plane slices as the distance from the mid-
contact point between the femoral condyles and tibial plateau to the patella tendon. 
The moment arm length was multiplied by 0.99 to adjust for the difference between 
full knee extension to 90° flexion (Baltzopoulos, 1995) (the angle at which MVC was 
measured) and the resulting value was multiplied by 1.14 to adjust for the 14% 
increase in moment arm in transition from rest to MVC (Tsaopoulos et al., 2007). This 
technique has a coefficient of variation of < 4% (Erskine et al., 2009). 
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Grip Strength 
Handgrip strength was measured with all participants instructed to maintain an upright 
standing position, arms down by the side, holding the dynamometer in the dominant 
hand without squeezing the arm against the body. Measurement was to the nearest 
0.1kg using a JAMAR hand dynamometer (Sammons Preston, Inc, Bolingbrook, IL, 
USA). Each participant had the dynamometer adjusted to their hand size, with the 2nd 
phalanx resting against the inner handle.  
Six-Minute Walk Distance 
To assess the 6-minute walk distance two cones were placed 20 m apart. Participants 
were given the verbal instruction to “complete as many circuits as possible without 
running” and received verbal encouragement after each minute of the walk. The total 
distance walked during the six-minute period was recorded (Enright, 2003). Heart rate 
was monitored throughout the test (Polar, USA) and the average heart rate during the 
final 3 minutes of the test was given as the steady state heart rate (S-shr). All 
participants completed the 6-minute walk without the use of a walking aid.  
Timed Up-and-Go  
The TUG test involved getting up from a standardised chair (no arm rests, seat 44 cm 
high) and to walk forward as quickly as they were able, without running, to a cone 3 m 
away and return to the initial sitting position. Participants were familiarised to the 
procedure prior to the execution of the real test. Upon the ‘go’ signal, participants rose 
from the chair and timing was concluded when seated again. The test was conducted 
three times for each participant, with a rest period of 1 min between trials, and the 
quickest of the three trials was recorded. 
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MVC and voluntary activation 
A custom-built isometric dynamometer was used to assess knee extension MVC of 
the dominant leg with participants sitting with the knee and hip angles at 90°. A strap 
was firmly secured across the hip joint and the lower leg securely strapped to the force 
transducer 2 cm above the malleolus. The linear distance from the estimated centre 
of knee rotation to the point of force application (2 cm above the malleolus) was taken 
as the lever length (in m). Torque was estimated as force multiplied by lever length. 
Force signals sampled at 2000 Hz were digitised for real-time visual display and for 
recording on a computer interface running Labview and a customised Matlab script 
(Matlab, the Mathwork Inc., S Natik, MA, USA). Participants were familiarised with the 
knee extension exercise by performing up to five contractions at around 50% of 
maximal effort each lasting 3 s, and another two contractions at around 80% maximal 
effort. After a 2 min rest, participants performed a maximal isometric contraction, 
sustained for 3 s with visual feedback and strong verbal encouragement and this was 
repeated a further two times. The highest recorded torque was taken as MVC. The 
patella tendon force was estimated from the moment equilibrium equation around the 
knee joint (Reeves et al., 2004a) by dividing the MVC torque by the patella tendon 
moment arm length. 
Voluntary activation was assessed using a version of the interpolated twitch technique 
(Rutherford et al., 1986b, McPhee et al., 2014) with stimulating electrodes covering 
the proximal and distal portions of the quadriceps (AmericanImex: Dispersive 
electrode, 4 x 7 inch), connected to a Digitimer DS7AH set at 400 V (Welwyn Garden 
City, UK) and current increased to deliver supramaximal ‘doublet’ (two 200-μs pulses 
separated by 10 ms) stimuli over the quadriceps muscle group. Stimulation was 
applied to the relaxed muscle 1 s prior to a maximal voluntary effort and then again at 
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the highest point of the MVC. In the cross-sectional study, a third doublet was also 
applied 2 s after the MVC. The voluntary activation test was performed twice and the 
result giving the highest voluntary activation was accepted. The percentage voluntary 
activation was calculated as: 
 % voluntary activation = 100 x (1 – t/T) 
Where t was the amplitude of the superimposed doublet (i.e. the size of the additional 
peak) and T the value of the doublet applied to the resting muscle 1 s prior to MVC.  
Physiological cross sectional area and in situ specific force 
PCSA was calculated for each quadriceps muscle as: [muscle volume / fascicle 
length], and the sum taken as quadriceps PCSA (Narici, 1999).  
The fascicle length and pennation angle used in these calculations were estimated 
using real-time B-mode ultrasonography with a 7.5-MHz linear array probe. 
Measurements were collected at the mid belly of each of the four heads of the 
quadriceps muscles in the sagittal plane at the moment of peak force during MVC 
contractions (Erskine et al., 2009). Imaging software (Image J; v1.39b; National 
Institutes of Health, Bethesda; USA) was used to determine muscle fascicle length 
from the superficial to the deep aponeurosis. Pennation angle was determined as the 
angle at which the fascicles intercepted the deep aponeurosis. Thickness was 
measured as the perpendicular distance between the superficial and deep 
aponeurosis.  
For calculations of in situ specific force, the quadriceps PCSA was multiplied by the 
cosine of the fascicle pennation angle to account for the reduction in transmission of 
forces from fibres to aponeurosis to adjust for the angle between the fascicles and the 
line of pull through the patella tendon. Specific force was estimated as: [(external 
torque / moment arm) / (PCSA * pennation angle)] or simplified to: [Patella tendon 
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force / (PCSA * pennation angle)] (Erskine et al., 2009). The external force used in the 
calculation of specific force was the “true MVC”, which is the estimated MVC if full 
voluntary activation was possible: True MVC = MVC immediately prior to the 
superimposed doublet / (1 – t/T). Where t was the amplitude of the superimposed 
doublet (i.e. the size of the additional peak) and T the value of the doublet applied to 
the resting muscle 1 s prior to MVC. 
Muscle morphology 
Muscle biopsies available from young and old participants were taken using a 
conchotome from midway along the length of the right vastus lateralis muscle (VL) 
under aseptic conditions and local anaesthesia (1% lignocaine). The samples were 
placed on cork with fibres running vertically and immediately frozen in liquid nitrogen 
whilst shaking vigorously to avoid freezing artefacts. Muscle sections were stained for 
myosin ATPase activity after preincubation at pH 4.35 to identify type I and type II 
fibres and determination of the fibre cross-sectional areas (FCSA). Serial sections 
were stained with Sirius Red to assess the collagen content and analysed using a 
customised Matlab programme. The total numbers of fibres in the VL PCSA was 
estimated as: [VL PCSA / average FCSA]. Biopsies were not collected in the 
longitudinal follow-up study. 
Statistical analysis 
The Shapiro-Wilk test showed that all data were normally distributed. A two-way 
ANOVA was used to test for age and gender effects of outcome parameters. 
Pearson’s Product Moment Correlations were used to assess the relationship between 
variables. Changes occurring over the 5-year follow-up period were assessed using 
paired samples t-tests. Two stepwise multiple regression models were used to identify 
factors associated with MVC torque: the first for baseline and the second for follow-up 
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changes. Both included quadriceps volume, voluntary activation, VL fascicle 
pennation angle, patella tendon moment arm length, age and gender. The second 
model was adapted to examine predictors of longitudinal changes in MVC torque and 
used the percentage changes in each of these variables. Standardised beta 
coefficients (β) indicate the change in standard deviation of MVC torque per standard 
deviation change in the independent variable. Statistical testing was completed using 
SPSS (IBM v.23. USA) and significance was accepted as P<0.05. Results are reported 
as mean and standard deviation (SD), unless otherwise stated. 
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3.4 Results 
 
Table 3.1. Participant characteristics 
Baseline study of young and older adults Longitudinal study of older adults 
 YM 
(n = 16) 
YW 
(n = 15) 
OM 
(n = 20) 
OW 
(n = 20) 
P value:  
Gender 
P value: 
age 
O vs Y 
(%) 
Baseline 
(n = 23) 
Follow-up  
(n = 23) 
P value: 
 
Change (%) 
Age (yrs) 23 ± 4 22 ± 2 72 ± 5 71 ± 4    71 ± 4 76 ± 4   
Height (m) 1.79 ± 0.06 1.67 ± 0.06 1.74 ± 0.08 1.60 ± 0.07 <0.001 0.001 -3 1.68 ± 0.10 1.67 ± 0.10 0.001 -1 
Body mass (kg) 70.6 ± 8.3 61.2 ± 10.7 78.9 ± 14.4 67.3 ± 12.0 0.008 0.014 11 73.2 ± 14.8 73.4 ± 16.1 0.730 0 
BMI (kg·m-2) 21.3 ± 2.2 21.6 ± 3.6 25.9 ± 2.8 26.3 ± 4.1 0.625 <0.001 19 26.0 ± 4.8 26.4 ± 4.7 0.126 1 
Body fat (%) 16.2 ± 6.6 29.6 ± 8.4 30.2 ± 7.8 39.7 ± 8.3 <0.001 <0.001 47 32.6 ± 10.4 33.5 ± 10.1 0.049 3 
ALM (kg) 24.2 ± 1.9 15.1 ± 1.9 20.9 ± 4.0 13.1 ± 2.1 <0.001 <0.001 -13 19.9 ± 5.0 19.3 ± 4.7 <0.001 -3 
ALM·h-2 (kg·m-2) 7.6 ± 0.6 5.4 ± 0.5 6.9 ± 0.8 5.1 ± 0.7 <0.001 0.005 -8 6.9 ± 1.0 6.8 ± 0.8 0.070 -1 
Grip strength (kg) 48.6 ± 12.1 34.3 ± 6.6 37.6 ± 7.7 25.3 ± 4.5 <0.001 <0.001 -24 32.2 ± 9.0 33.1 ± 7.9 0.799 3 
TUG (s) 3.9 ± 0.4 4.2 ± 0.3 5.1 ± 0.8 5.6 ± 1.0 0.083 <0.001 32 5.2 ± 0.7 6.6 ± 1.2 <0.001 27 
6 min walk (m) 735 ± 40 683 ± 45 562 ± 60 551 ± 87 0.081 <0.001 -21 563 ± 79 507 ± 69 <0.001 -10 
 
Data shown as mean ± SD. Abbreviations: YM: young men; YW; young women; OM: older men; OW: older women. BMI: body mass index; ALM: appendicular lean mass; TUG: timed-up-and-go. 
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Muscle size, strength and specific force 
Table 3.1 provides the data for grip strength, TUG and 6-min walk, as well as ALM 
and ALM/h2 and the data show the older adults to be sarcopenic (Cruz-Jentoft et al., 
2019). There were no significant age x gender interactions for any of the 
measurements, indicating that the effects of age described here apply similarly to men 
and women. 
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Figure 3.1. Knee extensor size and strength measurements in young and older men and women. A) 
knee extensor MCV torque; B) MVC patella tendon force; C) quadriceps physiological cross-sectional 
area (PCSA); D) the relationship between patella tendon force and quadriceps PCSA for young (shaded 
circles, continuous line) and older (filled circles, dashed line) adults. Data shown as mean ± SD (Figs 
3.1A-C) and individual data points (Fig 3.1D). Abbreviations: MVC: maximal voluntary torque; PCSA: 
quadriceps physiological cross sectional area; YM: young men; YW: young women; OM: older men; 
OW: older women. P values indicate the results of a two-way ANOVA; age x gender interactions were 
not significant for any of these measurements. 
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The MVC torque (Figure 3.1A) and peak patella tendon force (Figure 3.1B) in old were 
37% and 39%, respectively, lower than values for young. Quadriceps PCSA was 25% 
lower in old than young (Figure 3.1C) and was positively correlated (R2=0.598; 
P<0.001) with tendon force (Figure 3.1D). The in situ specific force value for old was 
83% of values for young (Figure 3.2; P<0.001). 
 
Figure 3.2. Knee extensor in situ specific force. Data shown as mean ± SD. YM: young men; YW; 
young women; OM: older men; OW: older women. P values indicate the results of a two-way ANOVA; 
there was no significant age x gender interaction. 
 
During the 5 years of follow up, components of sarcopenia including ALMM and 
performance in the TUG and 6-min walk tests all decreased (Table 3.1). The 
percentage decrease from baseline values included 12% (±13) lower MVC torque, 6% 
(±9) lower quadriceps muscle volume, 5% (±9) lower PCSA and 4% (±6) lower 
79 
 
voluntary activation (all P<0.05), but the in situ specific force did not change 
significantly (3% (±11); Figure 3.3). 
 
Figure 3.3. Five-year changes to muscle torque, size, activation and specific force. Data from older 
adults only and shown as mean ± SD. * indicates significant change from baseline 
 
Predictors of MVC torque 
The regression model based on data from young and old explained 83% of the 
variation in external torque. The majority was due to quadriceps volume (adjusted 
R2=0.765; β=0.727; P<0.001) and a small contribution of age (adjusted R2=0.057; β=-
0.286; P<0.001). Gender, pennation angle, voluntary activation and moment arm 
length did not contribute significantly to the model. A similar result was found if 
quadriceps PCSA was used in the model rather than quadriceps muscle volume. The 
remaining 17% of the variation in external torque not explained by any variables in this 
model includes the contribution of muscle specific force. 
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The regression model based on longitudinal data explained 72% of the change in 
external torque, with the main factor being change in quadriceps volume (adjusted 
R2=0.510; β=0.730; P<0.001) and a contribution of change in voluntary activation 
(adjusted R2=0.210; β=-0.460; P=0.001). Gender, age, pennation angle and moment 
arm length did not contribute significantly to the model. 
Muscle fibre cross sectional area and estimated fibre numbers per PCSA 
Since the results comparing young with old and the longitudinal study point towards 
loss of muscle mass being the main determinant of low MVC in older age, additional 
analysis was completed to determine the relative contributions of fibre atrophy and 
fibre loss to the difference between young and old in VL PCSA. 
The relative area occupied by type I and type II fibres did not differ significantly 
between young and old (P=0.423) or between men and women (P=0.726) (type I: 
young men: 38.8 ± 11.7; young women: 37.3 ± 8.8; older men: 42.0 ± 12.8; older 
women: 40.8 ± 7.4%).  
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Table 4.2. Skeletal muscle characteristics 
 
Data shown as mean ± SD. Abbreviations: YM: young men; YW; young women; OM: older men; OW: older women; 
FCSA: fibre cross-sectional area (available from 13 young men, 8 young women, 20 older men and 10 older 
women); VL: vastus lateralis; VI: vastus intermedius; RF: rectus femoris; VM: vastus medialis. 
 
 
 
 
 
 
 YM 
(n = 16) 
YW 
(n = 15) 
OM 
(n = 20) 
OW 
(n = 20) 
P value:  
Gender 
P value: 
age 
O vs Y (%) 
Voluntary activation (%) 90.1± 3.7 92.2 ± 3.8 88.5 ± 5.9 90.9 ± 5.1 0.073 0.252 -1 
Moment arm (cm) 4.0 ± 0.2 3.3 ± 0.3 4.0 ± 0.3 3.4 ± 0.3 <0.001 0.447 3 
R. leg lean mass (kg) 10.3 ± 1.0 6.5 ± 0.8 8.8 ± 1.6 5.6 ± 0.8 <0.001 <0.001 -14 
R. Quads mass (kg) 2.2 ± 0.3 1.4 ± 0.2 1.6 ± 0.3 1.1 ± 0.2 <0.001 <0.001 -28 
VL fascicle length (mm) 
VL Pennation angle (deg) 
VL Thickness (mm) 
90.6 ± 11.3 
15.3 ± 2.9 
25.2 ± 3.2 
86.6 ± 12.0 
13.8 ± 1.8 
19.9 ± 2.9 
95.0 ± 13.9 
12.3 ± 2.1 
20.4 ± 3.5 
88.4 ± 10.1 
11.9 ± 1.4 
17.9 ± 2.8 
0.073 
0.061 
<0.001 
0.290 
<0.001 
<0.001 
4 
-17 
-15 
VI fascicle length (mm) 
VI Pennation angle (deg) 
VI Thickness (mm) 
100.5 ± 11.0 
12.0 ± 2.5 
21.1 ± 4.9 
92.5 ± 10.5 
10.9 ± 2.0 
18.2 ± 4.0 
93.3 ± 12.6 
11.9 ± 2.7 
19.0 ± 3.1 
87.4 ± 11.2 
10.5 ± 1.7 
15.9 ± 3.6 
0.014 
0.025 
0.002 
0.028 
0.699 
0.026 
-6 
-2 
-11 
RF fascicle length (mm) 
RF Pennation angle (deg) 
RF Thickness (mm) 
76.7 ± 16.0 
19.2 ± 4.0 
23.6 ± 4.2 
70.7 ± 10.8 
18.0 ± 2.4 
19.9 ± 4.0 
78.3 ± 20.0 
15.6 ± 3.1 
20.4 ± 4.3 
71.9 ± 19.7 
14.9 ± 2.7 
17.8 ± 5.0 
0.150 
0.084 
0.005 
0.738 
<0.001 
0.015 
2 
-20 
-12 
VM fascicle length (mm) 
VM Pennation angle (deg) 
VM Thickness (mm) 
94.7 ± 13.1 
20.8 ± 4.3 
31.3 ± 5.1 
74.1 ± 15.9 
19.5 ± 7.2 
21.5 ± 3.4 
87.5 ± 12.0 
19.6 ± 3.2 
26.6 ± 4.2 
74.9 ± 17.7 
15.3 ± 2.7 
19.3 ± 4.8 
<0.001 
0.011 
<0.001 
0.375 
0.014 
0.002 
-4 
-13 
-13 
Type I FCSA (µm2)  
Type II FCSA (µm2) 
4880 ± 690 
6110 ± 1330 
4180 ± 920 
4600 ± 650 
5230 ± 1940 
5000 ± 1440 
4160 ± 1190 
2960 ± 500 
0.708 
<0.001 
0.487 
<0.001 
4 
-26 
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There was no significant difference between young and old in type I FCSA (P=0.487), 
but type II fibres had 26% lower FCSA in old (P<0.001; Table 3.2). Considering the 
type I and type II fibres together, the overall FCSA was 15% lower in old than young, 
which would give approximately 9.5 cm2 smaller VL PCSA in old than young. However, 
the actual VL PCSA was 17.5 cm2 (28%) smaller in old than young, suggesting that 
fibre atrophy alone accounts for approximately 54% of the overall muscle atrophy and 
the remainder (46%) is due to old having fewer fibres than young. The estimated 
numbers of muscle fibres per VL PCSA (PCSA divided by FCSA) was 1.22 million in 
young and 1.03 million (15% fewer) in old. The old had a higher proportion of 
connective tissue than young (11.3 ± 1.0% in young and 14.2 ± 1.4% in old). Taking 
into account this 3% difference reduces the estimated number of fibres per VL PCSA 
to 1 million in old, which is 18% fewer than the young. 
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3.5 Discussion 
We have considered muscle quantity, quality and activation to understand the causes 
of muscular weakness (sometimes referred to as dynapenia, from the Greek for 
poverty of strength) in sarcopenia. The results show that 28% lower muscle mass was 
the main cause of weakness in old compared with young and a further decrease in 
muscle mass was the main predictor of progressing weakness over the follow-up 
period. In situ specific force was 17% lower in old compared with young and did not 
decrease further during the follow-up period. Voluntary activation was similar for young 
and old, but the 4% decrease over five years of follow-up contributed to the declining 
MVC torque. The lower muscle mass in older age was due in about equal proportions 
to fibre atrophy and loss of fibres. 
Knee extensor torque and size 
Low muscle mass is the criterion measurement for sarcopenia and can be estimated 
as ALM/h2. The average ALM/h2 of 6.9 kg/m2 for older men and 5.1 kg/m2 for older 
women at baseline were below the recommended sarcopenia cut-off values of 7.26 
kg/m2 for men and 5.5 kg/m2 for women (Cruz-Jentoft et al., 2019) . Components of 
sarcopenia further declined at follow-up (Table 4.1). In the results comparing young 
with older adults there was a 26-28% lower muscle size (PCSA and volume, 
respectively) and 37% lower MVC torque. If we assume muscle declines begin from 
age 30 years (Janssen et al., 2000b, Moore et al., 2014, Lynch et al., 1999, Silva et 
al., 2010), the rate of change is estimated to be 0.9, 0.7 and 0.4% per year, 
respectively, for MVC torque, quadriceps size and in situ specific force. A further 12% 
decline in MVC was observed over the 5 years follow-up of the older adults. This rate 
of decline is more than twice that estimated for the previous 40 years and is generally 
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in agreement with the literature highlighting accelerated deterioration with advancing 
older age (Mitchell et al., 2012).  
Our results suggest that the cause of muscle weakness during ageing to around age 
70 years is due to loss of muscle mass and, to a lesser extent, specific force. An 
important novel finding of the present study was that the further weakening into the 
late 70s is primarily attributable to continued decline of muscle mass and a lower 
voluntary activation. 
In situ specific force 
Recent reports suggest that muscle quality is the major determinant of strength in older 
age (Senechal et al., 2015, Clark and Manini, 2008). This literature is largely based on 
DXA studies to estimate lean mass, where only weak relationships are seen with MVC 
torque or force (Senechal et al., 2015, Clark and Manini, 2008, Lynch et al., 1999). 
These studies using DXA do not measure the agonist muscle size and in this respect, 
the MRI is the criterion technique and CT is also preferable to DXA (Lustgarten and 
Fielding, 2011). Our results using MRI do not support the literature stating a large 
discordance between muscle mass and strength in older adults. Rather, a positive 
relationship exists between quadriceps PCSA and patella tendon force in young and 
old (Figure 4.1), which is in keeping with the long-standing literature from MRI and CT 
imaging (Hakkinen and Hakkinen, 1991, Maughan et al., 1983, Young et al., 1984, 
Overend et al., 1992, Rutherford and Jones, 1992, Bamman et al., 2000).  
A large-scale longitudinal observation of muscle quality that included an accurate (CT) 
measurement of muscle size showed around 5% loss of thigh muscle CSA and 16% 
decrease in MVC force over 5 years in older men and women (Delmonico et al., 
2009b). This disproportionate loss of strength compared to mass was interpreted as 
reduced muscle quality being the decisive factor for weakness (Delmonico et al., 
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2009b). However, without a measurement of the neural activation, these findings alone 
should not be interpreted in this way. Because strength can decline due to subjects 
being less willing to perform a maximum contraction or less able to activate the motor 
unit pool, as has been demonstrated in our results and others have previously shown 
(Clark and Taylor, 2011, Harridge et al., 1999). We calculated voluntary activation 
using the superimposed doublet normalized to the pre-MVC doublet, based on the 
assumption that the superimposed stimulus activates motor units (muscle fibres) not 
recruited during the voluntary effort. Other studies normalized the superimposed 
stimulus to a stimulus applied 2 s after the MVC when the muscle response can be 
potentiated. Our cross-sectional study dataset includes both the “pre-stimulus” and the 
“post-stimulus” so we were able to compare the results. The average voluntary 
activation calculated for all participants pooled was 90.4% and 90.8% (p<0.001) when 
using the “pre-stimulus” and the “post-stimulus”, respectively. It therefore made no 
difference to results if the pre- or the post- stimulus was used to normalize the 
superimposed stimulus. 
The best estimate of the muscle quality comes from measurement of the in-situ 
specific force, which takes into account the agonist muscle size, architecture, 
activation of the motor unit pool and the patella tendon moment arm length. Our results 
show 17% lower specific force in old compared with young, which is similar to the 
findings of a previous study normalizing knee extensor isokinetic MVC to quadriceps 
anatomical cross-sectional area (Jubrias et al., 1997). We observed no significant 
change in specific force over the 5-year follow-up in older adults. This is the first 
longitudinal study of in situ specific force accounting for patella tendon force, PCSA 
and muscle architecture. One previous study measured specific force in a similar way 
to us, but comparing young and older plantar flexors. They reported that a 37% lower 
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Achilles tendon force in older muscle was mostly due to a lower (30%) specific force 
(Morse et al., 2005b). Their conclusion that muscle quality changes are more important 
than muscle quantity differs from our own, but closer inspection of the published 
results (Morse et al., 2005b) also reveals 28% lower muscle volume (Morse et al., 
2005b), which is in fact in agreement with our own findings that changes in muscle 
quantity are playing the largest role in age-related weakness. 
The results of the present and a previous publication (Erskine et al., 2009) reveal that 
the force / anatomical cross-sectional area (ACSA) gives a very similar age-related 
difference as the more comprehensively measured in situ specific force. In situ specific 
force is calculated as: [Patella tendon force / (PCSA * pennation angle)], where the 
patella tendon force is the force that could be produced if full voluntary activation was 
possible. Since the moment arm and the voluntary activation did not differ between 
young and old, the tendon force decreased proportional to that of torque. Furthermore, 
the lower PCSA in old was mainly due to a change in muscle volume because the 
fascicle length was similar for old and young and age-dependent differences in 
pennation angle have minimal influence on force transmission to the tendon. Thus, the 
age-dependent differences for in situ specific force are reasonably estimated from 
force / ACSA. 
In mice (Ballak et al., 2014), connective tissue accumulation was associated with lower 
specific force. The small increase in connective tissue in old compared with young in 
our study explains at best just 3% of the difference between young and old in specific 
force, since connective tissue makes up a relatively small proportion of the overall 
muscle. The lower specific force is likely due to lower specific tension of individual 
muscle fibres in old compared with young (D'Antona et al., 2003, Frontera et al., 
2000b, Brocca et al., 2017). We recently reported 16% lower single fibre specific 
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tension in old compared with young (Brocca et al., 2017) and this matches the 
estimates of the in situ specific force made in the present study. 
The age-dependent muscle atrophy 
Our results are consistent with previous reports that type II fibres are highly susceptible 
to age-related atrophy, while type I FCSA is well preserved (e.g. see (Barnouin et al., 
2017a, Andersen, 2003, Nilwik et al., 2013, Lexell and Taylor, 1991)). However, 
surprisingly little information is available about muscle fibre numbers in humans and 
the scarcity of information limits current understanding of the contributions of muscle 
fibre changes underpinning the overall atrophy. In the present study, fibre atrophy 
accounted for 54% of the difference between the PCSA of young and old. The 
remaining 46% is presumably due to fibre losses and we estimate that the old had 
around 200,000 fewer fibres than young in the VL cross section. Despite the selective 
type II atrophy, the relative area occupied by type I and type II fibres did not differ 
between young and old, which must mean that a greater number of type I fibres than 
type II is lost to balance the reduction in type II FCSA. These findings are in general 
agreement with data from autopsy examinations of the VL muscle, suggesting that 
loss of fibres and type II fibre atrophy both contribute to the loss of VL muscle mass 
with ageing, although the autopsy studies indicate similar proportional losses of type I 
and type II fibres (Lexell et al., 1988, Lexell and Taylor, 1991). 
A different conclusion was reached by Nilwick et al (2013), who reported that young 
and old men had similar fibre numbers and that loss of muscle mass with ageing was 
due to type II fibre atrophy only. Notably, Nilwick et al’s (2013) older subjects were not 
sarcopenic and thus had much larger quadriceps anatomical cross-sectional area 
(QACSA: 59 cm2 in our subjects and approximately 68 cm2 in Nilwik et al. (2013)), but 
similar FCSA and therefore higher fibre numbers than our older, sarcopenic 
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participants. These differences between studies may reflect differences between 
sarcopenic and non-sarcopenic old, or differences in the ageing process due to 
lifestyle and habitual activity patterns. 
Our estimate of 200,000 fewer fibres in the VL cross-section of old compared to young 
is similar to Lexell et al (1988) who estimated about 264,000 fewer fibres in 
septuagenarians compared with young adults. Lexell’s (1988) data show fibre 
numbers decline after age 30 years, which is the same age that muscle mass begins 
to decrease (Janssen et al., 2000b, Moore et al., 2014, Lynch et al., 1999, Silva et al., 
2010). It is highly likely that the other quadriceps muscles age in a similar way based 
on the fact that the different quadriceps muscles experience the same degree of 
atrophy (Maden-Wilkinson et al., 2013a) and undergo similar motor unit remodelling 
(Piasecki et al., 2016a, Ling et al., 2009). Given that the VL accounts for about 30% 
of the quadriceps mass, it can be estimated that 20,000 fibres are lost in each 
quadriceps muscle per year, or 40,000 fibres across both quadriceps muscles per 
year, from age 30 years, assuming linear progressive declines. The loss of fibres may 
be linked to declining numbers of motor units, as old have 30-50% fewer leg motor 
neurons than young adults (Tomlinson and Irving, 1977, Piasecki et al., 2016a). A 
resistance training programme will help to recover the type II fibre atrophy (Nilwik et 
al., 2013, Doherty, 2003b) and improve specific force (Reeves et al., 2004a), but is 
unlikely to recover lost fibres or motor units. 
Conclusions  
The in situ specific force declines relatively early during ageing and reduced voluntary 
activation of muscle occurs later, but the overall weakness in sarcopenia is mainly 
related to loss of both type I and type II muscle fibres and type II fibre atrophy. 
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Chapter 4 
 
 
Decrements of mobility and power in septuagenarians related to loss 
of force, but not slowing of the muscle; a 5-year longitudinal study  
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4.1 Abstract  
Previous work has found that the lower 6-minute walk distance (6MWD) was primarily 
due to intrinsic slowing of the muscle between young and old (Maden-Wilkinson et al., 
2015). Here we investigated the ageing-related reductions in mobility over a 5-year 
period in septuagenarians. We measured muscle power by a countermovement jump, 
MVC, quadriceps muscle size by MRI in 17 older women (71.1±2.8 y) and 17 older 
men (71.3±4.1y). 6MWD and TUG were used as indicators of ability to perform daily 
life tasks. Performance in TUG and 6MWD were reduced in both genders (P<0.001). 
TUG and 6MWD correlated with power at both baseline and follow up (R≥0.53; 
P≤0.001). Of the components of power, jump take-off velocity (VCMJ) correlated with 
6MWD and TUG (R≥0.54; P≤0.001). However, the relationship between ‘body mass: 
maximal force ratio’ with VCMJ was not significantly changed, the lower VCMJ was 
attributable to the muscles working at a higher relative load, hence a lower part of the 
force-velocity relationship, due to a reduction in MVC rather than slowing of the 
muscle. In conclusion, the additional decrement in 6MWD & TUG in older people is 
due to a loss of strength rather than further slowing of the muscle.  
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4.2 Introduction 
Globally, the proportion of people aged over 60 years is now growing rapidly.  In 2012 
there were already an estimated 810 million people over the age of 60, which is 
expected to rise to 2 billion by 2050 (United-Nations, 2012). A large proportion of older 
people suffer from limited mobility and loss of independence, placing a strain on 
healthcare resources. The ageing-related reductions in musculoskeletal function 
(dynapenia) and mass (sarcopenia) contribute to decreased mobility, and may 
ultimately lead to loss of independence and quality of life (McPhee et al., 2016). 
Counteracting or slowing musculoskeletal ageing might thus help to ease the burden. 
There are suggestions that the rate of ageing differs between people (Belsky et al., 
2015, Pollock et al., 2015), possibly due to differences in genotype, physical activity, 
lifestyle and diet (Degens and Korhonen, 2012), which raises the possibility of an 
optimal model of ageing. 
Athletic prowess (force and velocity) are thought to peak during the mid-20’s 
(Rittweger et al., 2009, Berthelot et al., 2012). Upon entering the 4th decade there is a 
noticeable and constant decline in performance and strength (Janssen et al., 2000c) 
with a possible accelerated decline after the age of 70 (Hughes et al., 2001b, Ganse 
et al., 2018, Nikolaidis, 2018). Close associations between declining muscle mass and 
functional performance have been widely reported (e.g. (Bijlsma et al., 2014, Janssen 
et al., 2002), suggesting a causal relationship. However, changes in muscle mass may 
not be the entire explanation since muscle force and power has been reported to 
decline proportionally more than muscle size with age (Morse et al., 2005a, Degens 
et al., 2009b, McPhee et al., 2018). Indeed, previous studies have shown that muscle 
force and power are much more closely related to the ability to perform activities of 
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daily living than muscle mass in older people (Buford et al., 2012, Maden-Wilkinson et 
al., 2015, Bean et al., 2002, Reid and Fielding, 2012). 
In addition to changes in muscle strength or power there are other factors that change 
with age and can affect performance of tasks related to mobility, such as a decline in 
neuromuscular coordination and cardiovascular function. Indeed, it has been shown 
that the performance in a 6MWT is related to the maximal oxygen consumption and 
performed at 80-86% of the measured maximal heart rate (Manttari et al., 2018). The 
ageing-related reduction in maximal heart rate (Tanaka et al., 2001) can thus 
contribute to a reduction in the performance in the 6-minute walk test. 
In 2015 the results of a cross-sectional study of young adults (average age 23 years) 
and older men and women (average age 72 yrs) were published (Maden-Wilkinson et 
al., 2015). In that study there was evidence of an association between the lower power, 
determined from a standing jump, and lower TUG and 6MWD performance, that was 
primarily attributable to intrinsically slower muscles of the old than young-adult people. 
Five years following the end of the aforementioned cross-sectional study, this study 
repeated the measurements on a sample of the original older study population. 
Assessing the changes that had occurred during this five-year period, and to what 
extent any additional reduction in performance of the TUG and 6MWD in recreationally 
active older people is attributable to further slowing and/or weakening of the muscle. 
We hypothesised that 1) the annual rate of decline in TUG, 6MWD and muscle function 
over 5 years in septuagenarians will be larger than that seen between 23 and 72 years 
of age, 2) any additional decrement in performance will be related to a further intrinsic 
slowing of the muscle. In addition, we explored possible effects of ageing-related 
changes in cardiovascular function and balance on these functional measures. 
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4.3 Methodology 
Participants and ethical approval 
The study received approval from the local ethics committee and was performed in 
accordance to the declaration of Helsinki. Participants were recruited from a subgroup 
in the framework of the MYOAGE study (www.myoage.eu) (McPhee et al., 2013). 
Thirty-five participants returned 5 years following the initial cross-sectional study from 
2009-2012 (base line). The follow up study was conducted between May 2015 and 
October 2015. The data of one woman are presented in figures, but not included in 
statistical analyses as her performance in the 6-minute walk and timed-up-and-go 
tests at follow up was more than 3 standard deviations below the average performance 
of the women at follow up (see her performance indicated with arrows in Fig. 1 & 2). 
The characteristics of the included participants are presented in table 1. Written 
informed consent was obtained at base line and for the follow up study from each 
participant. Exclusion criteria were: institutionalisation, unable to complete 250-m 
walking unassisted, co-morbidities such as heart failure, chronic pain syndrome, 
metabolic disease, chronic obstructive pulmonary disease and/or neurological 
disorders (e.g. Parkinson’s). Participants were also excluded if they had undergone 
hip or knee replacement in the previous 2 years, or had been immobilised for greater 
than 1 week 3 months prior to testing. All the participants were community dwelling 
and socially active. Participants were not known to suffer from musculoskeletal or 
cardiovascular disease, any limb fractures within 5 years of testing and were classed 
as healthy.           
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Anthropometrics   
The standing height of the participants was measured with a portable Stadiometer 
(SECA, Switzerland) to the nearest 0.1 cm. A digital scale (SECA, Switzerland) was 
used to record body mass with participants wearing light indoor clothing. The body 
mass index (BMI) was calculated as body mass divided by height squared. 
DEXA 
Participants wore a medical gown and laid supine on the scanning bed. A total body 
DXA (Lunar Prodigy Advance, GE Healthcare, Chicago, USA) scan was performed to 
measure total body composition. Estimations of FFM and FM mass were obtained 
using Prodigy, Encore 2006 v10.50.086 software (GE Healthcare). Each total body 
scan took 295 s with an estimated skin entrance dose of 0.4 µGy (GE Healthcare, 
Lunar encore, Safety and Specification Manual). The system was calibrated with the 
same phantom at baseline and at 5 years follow up before each scan. All DXA 
analyses were completed by the same investigator. Typically, the estimates of lean 
mass by DXA software packages include connective tissue, non-mineral components 
of bone and non-adipose components of fat tissue alongside muscle mass. As the 
contribution of these factors is uncertain and possible changes of these components 
with aging unknown, we did not correct for these potential confounders. 
Magnetic Resonance Imaging 
Thigh volume was measured using a 0.25-T MRI scanner (G-Scan, Esaote, Genova, 
Italy). The participant was in a supine position in the scanner and multiple 3.1-mm 
thick serial transverse sections were acquired every 25 mm from the proximal to the 
distal heads of the femur of the dominant leg, using a turbo 3D58 T1-weight protocol 
(matrix 256 x 256, TR 40 ms, TE 16 ms). The cross-sectional area of the quadriceps 
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muscle and other thigh muscles (hamstrings, abductors and adductors) in each slice 
were determined using computing imaging software (OsiriX medical imaging software, 
OsiriX, Atlanta, USA). The cross-sectional area of the quadriceps muscle (CSAQuad) 
was estimated using the maximal cross-sectional area from the serial transverse 
sections. Total cross-sectional area of the thigh musculature (CSAthigh) was estimated 
from the maximal cross-sectional area using previously outlined methods (Morse et 
al., 2007a, McPhee et al., 2009). 
Balance 
Balance was determined as described previously (McPhee et al., 2013). Testing 
encompassed two-leg and one-leg trials, firstly with eyes open and then with eyes 
closed. Participants attempted to stand still for a maximum of 30 s or until one of the 
termination criteria was fulfilled. Participants removed shoes and had a visible marker 
placed on a wall 2 m in front of the participant to provide a fixed point during the eyes 
open trials. Two legged trials were completed with arms relaxed and feet together, 
participants were not permitted to use their arms to maintain balance. One-legged 
trials required the contra-lateral leg held to be held 5cm off the ground.  All trails were 
repeated twice unless the participant failed to maintain balance for 30 s, in such cases 
a third trial was performed. Participants were encouraged to take some small steps 
between trials. Here we only report the time (in s) a person could stand on one leg 
with eyes open and eyes closed as a measure of balance. 
Six-Minute Walk Distance 
To assess the 6-minute walk distance two cones were placed 20 m apart. Participants 
were given the verbal instruction to “complete as many circuits as possible without 
running” and received verbal encouragement after each minute of the walk. The total 
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distance walked during the six-minute period was recorded (Enright, 2003). Heart rate 
was monitored throughout the test (Polar, USA) and the average heart rate during the 
final 3 minutes of the test was given as the steady state heart rate (S-shr).  All 
participants completed the 6-minute walk without the use of a walking aid.  
Timed Up-and-Go  
The TUG test involved getting up from a standardised chair (no arm rests, seat 44 cm 
high) and to walk forward as quickly as they were able, without running, to a cone 3 m 
away and return to the initial sitting position. Participants were familiarised to the 
procedure prior to the execution of the real test. Upon the ‘go’ signal, participants rose 
from the chair and timing was concluded when seated again. The test was conducted 
three times for each participant, with a rest period of 1 min between trials, and the 
quickest of the three trials was recorded. 
Cardiac Output Measures 
Blood pressure and heart rate were taken from the left arm, using an upper arm blood 
pressure monitor (M2, Omron, Kyoto, Japan). From the diastolic and systolic blood 
pressures the mean arterial (MAP) and pulse pressure (PP) were calculated.  The 
maximal heart rate (HRmax) was estimated as (Tanaka et al., 2001): 
HRmax = 208 – (0.7 x Age) 
and (resting) stroke volume (SV) was calculated as (de Simone et al., 1999): 
SV = PP x (0.013 x body mass – 0.007 x age – 0.004 x HRrest + 1.307) 
The SV and HRrest allowed us to calculate (resting) cardiac output (CO) and peripheral 
resistance (Rper) (in mmHg·mL-1·min): 
Rper = MAP / CO 
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Maximal Cardiac ouput (COmax in L·min·-1kg-1) was estimated as: HRmax * SV/BM. 
Muscle Power 
A maximal countermovement jump was performed on a force platform (Leonardo, 
Novotec Medical, Pforzheim, Germany) to measure the power of the leg extensor 
muscles. The participant was asked to perform the test three times (hands on the waist 
and no swing), with a 1-min rest between jumps. The best jump was selected for 
further analysis. The vertical component of the ground reaction force was used to 
calculate: jump height (m), maximal force (kN), maximum power of the concentric 
phase (Watts) and take-off velocity during the countermovement jump (VCMJ in m·s-1) 
(Caserotti et al., 2001). Jump velocity at take-off was calculated as: 
v = a ×  tf / 2 
Where ‘a’ is the gravitational acceleration (9.81 m s-2) and ‘tf ‘ the flight time of the 
jump. The flight time was the time from take-off until landing (the point which forces 
were registered on the platform again) (Degens et al., 2019).   
 
Isometric maximal voluntary contraction torque 
Isometric knee extensions were performed with the right leg on a custom-made 
isometric testing dynamometer (Designed by the Department on Physical and Medical 
Technology, VU University, Amsterdam, The Netherlands). Force signals were 
recorded via customised Labview (National Instruments Corporation, Texas, USA) 
and Matlab software (Matlab, the Mathwork Inc, S Natik, MA, USA). All procedures 
were explained to the participants, emphasising the requirement to stay relaxed and 
only to voluntary contract when instructed to do so. The participants were seated on 
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the dynamometer with a knee angle of 90° (full extension being 0°) and 85° hip flexion 
(supine being 0°). The lower leg of the participants was securely fastened to the force 
transducer, 2 cm above the ankle malleolus. The hip joint was firmly held in place via 
a strap. Prior to the measurements, the participants were familiarised to the knee 
extension exercise with three contractions at around 50% of maximal effort lasting 3 s 
each, followed by two further contractions at around 80% maximal effort lasting 3 s 
each. A two-minute rest was given prior to a MVC sustained for around 3 s. Two or 
more maximal contractions were performed until the two highest values were within 
10%, with the highest value taken as MVC. Verbal encouragement and visual 
feedback were conveyed during the testing. This method was tested for reproducibility 
in a validation study (Appendix 1). 
Statistics  
Data was analysed using SPSS v22 (IBM, 2015). A repeated-measures two-way 
ANOVA with as within factor Time (baseline vs. follow up) and between factor Gender 
was used to examine differences over time and between genders. To determine 
relationships between the dependent variables (6MWD & TUG) and independent 
variables linear regression models were used. Data were expressed as mean ± 
standard deviation unless stated otherwise and differences were considered 
significant at P<0.05. 
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4.4 Results 
Participant characteristics and muscle mass 
 Table 4.1 Men were heavier and taller than women (P<0.001). Both men and women 
became around 1 cm shorter over the 5-year period (P<0.001). There was a 
gender*time interaction for BMI (P=0.045) reflected by a decrease in BMI in women 
and an increase in men. Women had a lower FFM (P<0.001) and higher %FM 
(P=0.025) than men. Both genders lost FFM (P≤0.001), but there was no significant 
change in FM or %FM over the 5-year period. Appendicular lean mass, sarcopenia 
index, CSAQuad and CSAthigh all decreased over time (P<0.001), with men losing more 
CSAQuad than women (time * gender interaction, P=0.029). 
Table 4.1. Participant characteristics 
          
  Women (n=17) Men (n=17) Effects 
  Baseline Follow-up  % change Baseline Follow-up  % change Time Gender Gender*Time 
Age (years) 71.1±2.8 75.9±2.6  71.3±4.1 75.9±4.4  P=0.000 P=0.924 P=0.562 
Body mass (kg) 65.8±10.5 64.2±11.3 -2.74 84.2±15.5 84.4±15.4 0.24 P=0.174 P=0.000 P=0.093 
Height (m) 1.61±0.07 1.59±0.06 -1.24 1.75±0.07 1.74±0.07 -0.57 P=0.000 P=0.000 P=0.774 
BMI (kg·m-²) 25.8±5.34 25.5±5.56 -1.16 27.6±4.47 28.0±4.20 1.45 P=0.905 P=0.186 P=0.045 
FFM (kg) 39.0±3.04 37.9±3.20 -2.82 56.2±7.37 55.2±6.91 -1.78 P=0.002 P=0.000 P=0.861 
FM (kg) 24.5±9.60 24.1±10.5 -1.63 24.7±10.5 25.8±10.5 4.45 P=0.376 P=0.798 P=0.107 
FM (%) 37.4±9.34 37.4±10.0 0.00 29.4±8.75 30.8±8.51 4.76 P=0.163 P=0.025 P=0.163 
ALM (kg) 17.4±1.80 16.8±1.76 -3.45 26.2±3.60 25.0±3.29 -4.58 P=0.000 P=0.000 P=0.063 
Sarcopenia index (kg·m-²) 6.70±0.46 6.56±0.41 -2.09 8.58±0.88 8.28±0.68 -3.50 P=0.001 P=0.000 P=0.174 
CSAQuad (cm²) 44.2±6.27 42.8±5.94 -3.17 64.6±9.99 58.7±7.95 -9.13 P=0.000 P=0.000 P=0.029 
CSAthigh (cm
2) 94.0±18.8 89.1±17.2 -5.21 125±33.3 118±32.6 -5.60 P=0.000 P=0.005 P=0.294 
          
BMI: Body Mass Index; FFM: Fat Free Mass; FM: Fat Mass; ALM: Appendicular Lean Mass; CSAQuad: cross-sectional area 
quadriceps muscle; CSAthigh: cross-sectional area thigh  
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Balance, TUG and 6MWD  
 Both men and women had a decrease in balance time with eyes open (Table 4.2; 
P<0.001) and eyes closed (Table 4.2; P<0.05). Women needed more time to complete 
the TUG than men (P=0.003), but covered a similar 6MWD. For both men and women, 
the performance in the TUG and 6MWD test decreased over the 5-year period (Table 
4.2; P<0.001). 
Table 4.2. Measures of mobility 
          
  Women (n=17) Men (n=17) Effects 
  Baseline Follow-up  % change Baseline Follow-up  % change Time Gender Gender*Time 
1legEO (s) 25.3±8.03 17.8±10.5 -29.64 24.6±9.20 15.2±10.0 -38.21 P=0.000 P=0.610 P=0.554 
1legEC (s) 6.53±5.34 3.31±1.97 -49.31 5.95±5.21 3.93±1.92 -33.95 P=0.015 P=0.984 P=0.562 
TUG (s) 5.68±0.59 7.07±1.21 24.47 5.11±0.59 6.01±0.85 17.61 P=0.000 P=0.003 P=0.150 
6MWD (m) 533±83 494±69 -7.32 568±59 514±59 -9.51 P=0.000 P=0.226 P=0.434 
S-Shr 119±12 113±11 -5.04 111±17 104±15 -6.31 P=0.000 P=0.106 P=0.759 
6MWD % HRmax 75.7±10 73.2±7.3 -4.4 69.8±11.1 66.6±9.3 -4.58 P=0.001 P=0.086 P=0.665 
          
1legEO: one leg balance eyes open; 1legEC: one leg balance eyes closed; TUG: timed up and go; 6MWD: six-minute walk 
distance; S-Shr; six-minute walk steady state heart rate; 6MWD % HRmax: six-minute walk percentage of maximum 
predicted heart rate  
 
Cardiovascular parameters and Muscle function  
 There was an increase in resting HR (Table 4.3; P=0.006), and decreases in BPdia 
(Table 4.3; P=0.027) and calculated maximal cardiac output (Table 4.3; P=0.004). 
Other cardiovascular parameters did not change significantly over the 5-year period. 
 Standing jump power, VCMJ, standing jump force and MVC of knee extensor muscles 
were all higher in men than in women (Table 4.4; P≤0.001), with both genders showing 
a decrease in power, VCMJ and MVC over the 5-year period (Table 4.4; P≤0.005).  
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Table 4.3. Cardiovascular parameters  
          
  Women (n=17) Men (n=17) Effects 
  Baseline Follow-up  % change Baseline Follow-up  % change Time Gender Gender*Time 
HRrest (bpm) 68.6±7.19 73.6±8.56 7.29 64.6±8.80 67.5±7.71 4.49 P=0.006 P=0.067 P=0.551 
BP Dia (mmHg) 80.7±11.3 74.0±8.73 -8.30 83.0±9.6 82.5±7.8 -0.60 P=0.027 P=0.086 P=0.056 
BP Sys (mmHg) 136±18.1 129±21.0 -5.15 135±17.5 135.±16.2 0.00 P=0.130 P=0.667 P=0.124 
MAP (mmHg) 93.4±27.0 93.3±11.8 -0.11 93.8±26.6 94.1±25.8 0.32 P=0.992 P=0.920 P=0.974 
Pulse Pressure (mmHg 55.6±14.5 55.0±17.1 -1.08 52.3±12.1 52.9±13.1 1.15 P=0.995 P=0.574 P=0.741 
Stroke Volume (mL) 77.7±24.4 72.7±25.3 -6.44 86.7±27.0 85.5±26.1 -1.38 P=0.312 P=0.225 P=0.518 
Cardiac Output (mL/min) 5.29±1.67 5.38±2.14 1.70 5.54±1.79 5.72±1.63 3.25 P=0.576 P=0.637 P=0.842 
Rper (mmHg-min-mL-1) 20.1±5.16 19.1±5.62 -4.98 19.3±4.47 18.8±5.28 -2.69 P=0.364 P=0.752 P=0.792 
COmax (mL·min-1·kg-1) 173±60.3 149±52.9 -13.8 194±64.1 176±55.1 -9.30 P=0.004 P=0.244 P=0.643 
          
          
HRres: Heart rate at rest; BPdia: diastolic blood pressure; BPsys: systolic blood pressure; MAP: mean arterial pressure Rper: peripheral 
resistance COmax: cardiac output maximum 
 
Table 4.4. Muscle function 
          
  Women (n=17) Men (n=17) Effects 
  Baseline Follow-up  %change Baseline Follow-up  % change Time Gender Gender*Time 
Standing Jump Power (W·kg-1) 23.7±5.9 21.6±5.0 -8.86 29.9±4.7 26.7±4.8 -10.70 P=0.000 P=0.003 P=0.277 
VCMJ (m·s-1) 1.94±0.19 1.81±0.18 -6.70 2.22±0.19 2.18±0.26 -1.80 P=0.009 P=0.000 P=0.171 
Standing Jump Force (kN) 1.32±0.32 1.38±0.26 4.55 1.76±0.40 1.82±0.30 3.41 P=0.166 P=0.000 P=0.978 
Knee Extensor MVC (N) 417±72 366±75 -12.23 595±83 518±108 -12.94 P=0.000 P=0.000 P=0.344 
          
VCMJ : take-off velocity during the countermovement jump; MVC: Maximal voluntary torque 
 
Correlations of mobility with cardiac output and muscle function  
In follow up, the S-shr during the 6MWD and the distance covered in the test were 
lower than at baseline (Table 4.2; P≤0.001). The %HRmax during the 6MWD was also 
reduced (Table 4.2; P≤0.001), suggesting that the reduction in maximal heart rate is 
not the sole explanation for the reduction in 6MWD performance. 
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Figure 4.1. The relationship between A-C) 6-minute walking distance (6MWD; m) and D,F) timed up-
and-go (TUG; s), with A,D) power (W/kg), B,E) maximum voluntary torque / body mass (MVC-BM-1; 
Nm·kg-1), C,F)  take-off velocity during the countermovement jump (VCMJ; m·s-1). ■: men and ●: women 
at baseline, and □: men and ○: women at follow up. ---: regression line at baseline; -·-: regression line 
at follow-up. Regression equation left at baseline, right at follow-up. Arrow indicates woman with poor 
performance in follow up. 
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 Figure 4.1 showed only at follow up did balance, in terms of the time standing on one 
leg with eyes closed, correlate with the 6MWD (R=0.47; P=0.002) and TUG (R=0.39; 
P=0.01). Both at baseline (R=0.56; P<0.001) and follow up (R=0.61; P<0.001) the 
6MWD correlated with power (Fig. 4.1A). The performance in the 6MWD did not 
correlate significantly with MVC·BM-1 (Fig. 4.1B), but did correlate with VCMJ (Fig. 4.1C) 
at baseline (R=0.57; P<0.001) and follow up (R=0.57; P<0.001).  
Figure 4.1D shows a positive correlation (indicated by the negative slope) between 
power and performance of TUG at baseline (R=0.67; P<0.001) and follow up (R=0.53; 
P<0.001). The MVC·BM-1 correlated to TUG at both baseline (R=0.30 P=0.041) and 
follow-up (R=0.59 P=0.000) (Fig. 4.1E). The performance of the TUG also correlated 
positively with VCMJ (Fig. 4.1F) at baseline (R=0.71; P<0.001) and follow-up (R=0.543; 
P<0.005).  
Velocity and body mass 
 VCMJ was inversely correlated with the BM·MVC-1 ratio both at baseline and follow-up 
(both R>0.54; P<0.001; Fig. 4.2). The % change in power was not significantly related 
to baseline power (Data not shown; R=0.196 P=0.133). 
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Figure 4.2. Body mass / MVC (kg·Nm-1) with velocity (m·s-1). ■: men and ●: women at baseline, and □: 
men and ○: women at follow up. ---: regression line at baseline; -·-: regression line at follow-up. 
Regression equation left at baseline, right at follow-up. Arrow indicates woman with poor performance 
in follow up. One person performs poorly in both the 6MWD and TUG during follow up (indicated with 
an arrow in all figures)  
 
Note that one person performed poorly in both the 6MWD and TUG during follow up 
(indicated with an arrow in all figures). This person had an S-shr in the normal range 
during the 6MWD, but low power. This low power was attributable to a reduction in the 
force generating capacity and not so much slowing of the muscle as the lower VCMJ 
was as expected from the BM·MVC-1 for this person. 
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4.5 Discussion 
The novel observation in this longitudinal study was that healthy septuagenarians 
suffer from a significant decline in muscle mass/function and mobility over a 5-year 
period, irrespective of gender. The annual decline was larger than that observed in a 
previous cross-sectional study comparing 23- and 72-year-old people (Maden-
Wilkinson et al., 2015), suggesting an accelerated age-related decline beyond the age 
of 70. Muscle power, determined with a countermovement jump, correlated most with 
performance in the 6-minute walk and timed up-and-go tests, at both baseline and 
follow-up, while balance was associated with performance at follow-up only. The loss 
of power in the septuagenarians was primarily due to a reduction in force generating 
capacity, rather than a further slowing of the muscle. These results suggest that 
muscle power is a key determinant of physical function during relatively long- and 
short-duration physical function tasks and that with advancing older age balance is of 
increasing importance for physical function. 
Decline in muscle function and physical function  
The main defining features of sarcopenia are low muscle mass, weakness and 
reduced physical function (Fried et al., 2001, Cruz-Jentoft et al., 2019). The ALM/h2 
were at baseline and follow-up above the sarcopenia cut-offs for men (7.26 kg·m-2) 
and women (5.5 kg·m-2) (Cruz-Jentoft et al., 2019), suggesting that our participants 
were not sarcopenic according to the accepted cut-points. While an increase in TUG 
time is associated with an amplified risk of a falling, decline in physical function and 
an increase in frailty index (Beauchet et al., 2011, Viccaro et al., 2011, Kojima et al., 
2015), the TUG time at follow up was still (except the woman excluded from analysis) 
well below the 12-s cut-off point for normal mobility (Bischoff et al., 2003), suggesting 
they were neither physically frail. Similarly, the 6MWD is commonly used to assess 
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functional capacity (Enright and Sherrill, 1998, Troosters et al., 1999). As with the TUG 
test, even though performance in the 6MWD decreased over the 5-year period, all 
participants (again except the excluded woman) covered ≥ 400 m at follow up, 
considered the cut-off for mobility limitations (Abellan van Kan et al., 2011). These 
observations thus indicate that the participants in our study were not sarcopenic 
according to the cut-offs for skeletal muscle mass, nor (except one older woman at 
follow-up) physically frail, but rather a population of healthy ageing.  
Accelerated decline 
The annual reduction in 6MWD and TUG performance was larger in the present 
longitudinal study (0.9 & 4.2%, respectively) than that calculated from a previous 
cross-sectional study (0.4 & 0.7%) (Maden-Wilkinson et al., 2015). This and the annual 
decline in jumping power of 0.8% from a previous study (Maden-Wilkinson et al., 2015) 
compared to 2.0% in the present longitudinal study, suggest an accelerated decline in 
functional capacity beyond the age of 70 years. These calculations assume that 
human peak performance occurs early in the third decade, something that has been 
observed in master athletes of several disciplines (Ganse et al., 2018, Berthelot et al., 
2012). Therefore, our findings suggest an accelerated decline in muscle power in the 
8th decade of life cannot solely be due to decreased physical activity levels, since 
similar declines are evident even in athletic populations (McPhee et al., 2018, Frontera 
et al., 2000a, Frontera et al., 2008, Lazarus and Harridge, 2017, Degens, 2012). If that 
decline continues to progress at the same, or even an accelerated, rate it will ultimately 
result in a transition from an independent to a dependent lifestyle, even in our 
population who were non-sarcopenic and free from physical limitations in daily life. It 
is therefore important to uncover the ageing-related changes that elicit these accrued 
deficits in functional capacity. 
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Contribution of aerobic component and balance to the decline in 6MWD and 
TUG 
Part of the poorer performance in the TUG and 6MWD during follow-up was 
associated with an impaired balance, something also reported previously in people > 
70 years (Chen and Chou, 2017). Even before the age of 70, a significant reduction in 
balance occurs (Onambele et al., 2006). However, the absence of significant 
correlations between balance, assessed as the duration one could stand on one leg 
with eyes closed, with 6MWD and TUG performance at baseline suggests that only 
after the balance impairment exceeds a certain threshold it becomes a limiting factor 
for daily life performance.  
The 6MWD clearly requires an aerobic component and it is related to the maximal 
oxygen consumption of healthy young-adults and older people (Manttari et al., 2018). 
The heart rate measured during the 6MWD was decreased over the 5-year period both 
as absolute values and when expressed relative to the estimated age-predicted 
maximum. This reflects both a decrease in cardiovascular function and a decrease in 
the relative effort that the older adults were willing to put in when walking. It is not clear 
why less effort would be applied during the walk and our study methodology cannot 
reveal the reasons in any detail. However, it may be related to concerns over balance 
and the risk of falling. This supports previous studies of people aged > 70 years (Chen 
and Chou, 2017) and suggests that deterioration of balance makes an increasing 
contribution to physical functional declines with advancing age, either directly as 
adjustments are made with each step to control posture, or indirectly through more 
caution due to fear of falling. 
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Contribution of muscle function to the decline in 6MWD and TUG 
Previous studies have shown that the performance in the 6MWD and TUG tests are 
related to muscle mass and function (Song and Geyer, 2018, Maden-Wilkinson et al., 
2015, Bijlsma et al., 2014, Janssen et al., 2002). However, the relationship between 
functional limitation and muscle mass in older people is weak (Lauretani et al., 2003) 
or even absent (Maden-Wilkinson et al., 2015) and we show that power is more 
important. In the previous chapter we found that the ageing-related loss of muscle 
strength during early ageing is due to both a loss of muscle mass and quality, in terms 
of force generating capacity per unit muscle cross-sectional area, while in the 8th 
decade of life it is primarily due to a loss of muscle mass (McPhee et al., 2018). It is 
thus possible that in the oldest-old a low muscle mass becomes an increasingly 
important contributor to reduced functional capacity. Yet, we found neither a significant 
relationship between muscle mass and functional capacity at baseline nor at 5-year 
follow up. This confirms the increasing notion that not so much muscle mass, but rather 
muscle functional capacity is relevant as a determinant of the ability to perform daily 
life activities in the older population, even in people in the 8th decade of life. Given that 
power is the product of force and velocity one can understand that muscle power has 
been reported to better correlate with functional capacity than maximal voluntary 
isometric force in the older population (Reid and Fielding, 2012, Maden-Wilkinson et 
al., 2015). This was confirmed in our longitudinal cohort at both baseline and 5-year 
follow up. 
It has previously been shown that the difference in jump power between young and 
older subjects is in part due a reduction in force generating capacity and in part due to 
slower contractile properties of the muscle. While power increased with force, for a 
given jump force, power was greater in the young subjects (Maden-Wilkinson et al., 
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2015). This was attributed to a reduction in the intrinsic speed of shortening of the 
older muscle, probably a consequence of an ageing-related fast-to-slow transition in 
fibre type composition (Larsson and Ansved, 1995), preferential atrophy of fast fibres 
(Barnouin et al., 2017b) and/or a slowing of type I and type IIa muscle fibres (Larsson 
et al., 1997, Degens et al., 1998). 
However, when we looked further into this apparent slowing over the 5-year period, it 
appeared that there was no significant change in the body mass:maximal force ratio 
(Fig. 4.2). This means that both at baseline and follow-up, at a given ‘body 
mass:maximal force ratio’ the shortening velocity during the countermovement jump 
is the same. Given that body mass was not significantly changed over the 5-year 
period, but force was reduced by about 12%, the slower take-off velocity in the 
countermovement jump must have been the consequence of loss of force generating 
capacity. Thus, the actual culprit behind this apparent slowing of the muscle is that 
they are working at a higher relative load than 5 years prior, and therefore contracting 
more slowly according to the force-velocity relationship. Thus, while intrinsic slowing 
of the contractile properties was the main determinant of the ageing-related reduction 
in jump velocity between 23 to 72 years of age (Maden-Wilkinson et al., 2015), it is the 
loss of force that causes a further decline in power in the ageing septuagenarian. It 
should be noted that with ageing jumping kinematics are influenced, older individuals 
maximal hip, knee and ankle angular velocities are significantly decreased compared 
to young, with jump performance limited by reduced angular range of motion and loss 
of sequential pattern of joint coordination (Haguenauer et al., 2005). It remains to be 
seen if such changes continue to influence jumping kinematics during later ageing (71-
76 years). 
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An interesting pattern therefore arises that during early ageing (23-72 years) 
particularly intrinsic slowing contributes to the loss of power (Maden-Wilkinson et al., 
2015) and that weakening is the result of loss of muscle mass and quality (McPhee et 
al., 2018). On the other hand, during later ageing (71-76 years) loss of force, due to a 
loss of muscle mass and reduced voluntary activation (McPhee et al., 2018), but not 
further loss of muscle quality, is the primary contributor to the ageing-related loss of 
power. 
As previously mentioned this loss of power may eventually lead to a transition from an 
independent to a dependent life style. It has been shown; however, that muscle 
strength is positively related to physical activity levels in the older person (Latorre-
Roman et al., 2016). An increase in physical activity levels may thus reverse the loss 
of strength in the older person and improve functional performance. Indeed, resistance 
exercise is a potent means to improve functional performance, even in the oldest old 
(Fiatarone et al., 1990).  
Conclusion  
In conclusion, the ageing-related reduction in functional capacity over a 5-year period 
in healthy septuagenarians was to some extent attributable to a reduction in maximal 
heart rate and balance. However, a larger proportion of the decline in performance 
during a 6-min walk and timed up-and-go tests was explicable by a decline in muscle 
power. In contrast to the intrinsic slowing of the muscle between 23 and 72 years of 
age (Maden-Wilkinson et al., 2015), the further decrement in power and performance 
of the functional tests between 71 and 76 years of age was primarily attributable to 
loss of strength. This suggest that the process of muscle ageing may change from 
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decrements in both muscle mass and quality during early ageing to principally a 
reduction of muscle mass during later stages of ageing. 
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Chapter 5 
 
 
General Discussion 
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5.1 Aims and Objectives 
The overall aim of this thesis was to 1) assess longitudinal changes in muscle size 
and function over a 5-year period and 2) how these changes affected the ability to 
perform activities of daily life, in physically-independent older individuals. To achieve 
this the study had the following objectives: 
1) To assess the reliability of DXA measurements to assess longitudinal changes in 
muscle mass in older populations. 
2) To uncover the gross functional basis of the age-related changes in mobility seen 
in older individuals. 
3) To describe the influence of fibre atrophy, fibre loss, in situ specific force, and 
voluntary activation to muscle weakness seen with ageing.  
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5.2 Main observations  
Each of these Objectives was addressed in the studies described in Chapters 2-4, 
respectively. The detailed longitudinal examination of this population was a key part 
of the studies, and is unique where most studies on muscle ageing are cross-sectional. 
In addition, our study population was more homogenous than that in larger 
epidemiological studies of ageing which include a wide-ranging participant base, with 
many disabilities and co-morbidities. The participants in this study exhibited healthful 
ageing, being community dwelling, socially active, with no known musculoskeletal or 
cardiovascular diseases (McPhee et al., 2013). 
Ageing-related changes in muscle mass 
While the measurement of total volume by MRI is considered the gold standard, it is 
time consuming and costly. In Chapter 2, we showed that a single MRI scan at 60% 
of femur length could be used to accurately calculate muscle volume and changes 
therein in septuagenarians, as was previously shown in young men (Morse et al., 
2007a, Maden-Wilkinson et al., 2014). Reducing the time and cost required to perform 
such analysis, making MRI a more viable modality for larger cohort studies, allowing 
much greater detail to be described.  
Even so, MRI is not widely available or easy to use, while DXA is more widely available 
and commonly used in large cohort studies to measure muscle volume (Ellis, 2000, 
Visser et al., 2003, Goodpaster et al., 2006, Zhong et al., 2012, Santanasto et al., 
2017). While in Chapter 2 it was found that in both men and women DXA muscle 
volume measurements correlated well with MRI, DXA displayed a positive intercept 
with MRI and the slope of the regression line was greater than 1. As a consequence 
DXA consistently overestimated muscle volume, as seen in our previous work (Maden-
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Wilkinson et al., 2013b). However, the discrepancy over the 5-year time scale between 
DXA and MRI was relatively small, signifying that DXA is a viable and reliable method 
for tracking muscle mass longitudinal in older people. Extending the ability to identify 
changes in mass which may lead on to functional impair within older populations.    
Chapter 2 described muscle mass decreases of 5% over the 5-year period in 
septuagenarians, suggesting an accelerated decline in these older individuals when 
compared to the 25% change described between individuals in their twenties and 
seventies (Maden-Wilkinson et al., 2014). There was no differential rate of loss 
between quadriceps muscles and other muscles in the thigh, in contrast to what was 
reported in a previous cross-sectional study (Maden-Wilkinson et al., 2013b). We 
demonstrated that the relative rate of muscle mass loss with ageing was not related 
to baseline muscle mass, thus indicating the benefit of having a larger muscle mass 
to start with, as it will delay crossing the disability threshold of muscle mass until later 
in life (Degens, 2018, Degens and McPhee, 2013). While in previous studies the rate 
of muscle wasting was positively related to body fat percentage in women (Tomlinson 
et al., 2014) we observed this relationship in men only. A possible mechanism is that 
fat tissue may lead to muscle wasting due the release by fat of inflammatory cytokines 
resulting in chronic low-grade inflammation (Degens, 2010), which may impair the rate 
of nutrient stimulated muscle protein synthesis rates (Smeuninx et al., 2017). Though 
the influence of circulated inflammatory cytokines linked with obesity may have much 
wider influence on skeletal muscle size, architecture and strength (Erskine et al., 
2017). The contractile component of the total volume of the whole muscle is decreased 
with intramuscular fat infiltration seen with increased body fatness (Rahemi et al., 
2015). This in turn will influence muscle quality and intermuscular adipose tissue may 
be a predictor of muscle function in older populations (Beavers et al., 2013).  
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Ageing-related changes in muscle function 
The loss of muscle mass seen with ageing is inevitably associated with a loss of 
muscle strength, leading to deficits in functional performance. Having described 
changes in muscle mass longitudinally in Chapter 2, the contribution of fibre atrophy, 
fibre loss and reduction in voluntary activation to the muscle weakness was 
investigated in Chapter 3. It was observed that patella tendon specific force was 17% 
lower in old compared to young, but during a 5-year follow-up there was no further 
significant decrement in specific force in the older population. 
Using measurements of muscle volume and muscle architecture, the PCSA was 
calculated. In Chapter 3 it was estimated that 54% of the difference in PCSA between 
young and old was due to fibre atrophy, with fibre losses accounting for the remaining 
46%. The number of fibres lost was an estimated 200,000, and must have been 
preferential loss of type I fibres, due to the lack change seen in the relative area 
occupied in the muscle by type I and type II fibres between young and old in the face 
of preferential type II fibre atrophy. Others (Nilwik et al. (2013) did not find evidence 
for fibre loss, and in their study the age-related atrophy could be entirely explained by 
muscle fibre atrophy. A possible explanation of this discrepancy is that their subjects 
had much larger muscles than our subjects, and they were non-sarcopenic in contrast 
to our subjects. Whatever the explanation for this discrepancy, the loss of fibres in our 
study is thought to be linked to the loss of motor units seen with ageing (30-50% fewer) 
(Piasecki et al., 2016b, Tomlinson and Irving, 1977). Overall, the data suggested that 
loss of muscle mass was the main cause of the age-related muscle weakness, but 
there is also a significant contribution of a loss of muscle quality, defined here as 
specific force (force per PCSA), as also found by others (Morse et al., 2005a). 
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In a murine model, it was shown that part of the lower specific force in old animals was 
due to accumulation of connective tissue (Ballak et al., 2014). In our study this only 
accounted for 3% of the variation seen. In addition, we reported a preferential atrophy 
of type II fibres that may have a 40% higher specific tension than type I fibres (Bottinelli 
et al., 1996), though others report no significant difference in specific force between 
fibre types (Ottenheijm et al., 2005, Degens et al., 2009b). Nevertheless, even if we 
assume such a difference in specific tension, the change in areal fibre type proportion 
is too small to have a significant impact. It is possible that the lower specific force of 
the muscle is primarily due to lower specific tension of individual muscle fibres, which 
has been reported to be 16% lower in old vs young (Brocca et al., 2017, D'Antona et 
al., 2003, Larsson et al., 1997), matching with the data reported here.  
Ageing-related changes in mobility related to changes in muscle function 
Sarcopenia is considered an important factor in frailty in older people (McPhee et al., 
2018, Maden-Wilkinson et al., 2015, McPhee et al., 2016). The aim of Chapter 4 was 
to assess the relationship between changes in muscle function with changes in 
performance of daily life activities in a 5-year longitudinal study of septuagenarians. 
A significant decline was shown in all measurements of physical function and muscle 
function, with the annual decline in muscle force generating capacity being much 
larger than that shown in our previous cross-sectional study between young and older 
individuals (Maden-Wilkinson et al., 2015). More specifically, the 6MWD and TUG 
showed an annual decline of 0.9% and 4.2% over the 5-year period, in comparison to 
a 0.4 and 0.7%, respectively, in the preceding years. The annual decline in jumping 
power was 2.0% compared to the 0.8% suggesting an accelerated decline in muscle 
power in the oldest old (Degens and Korhonen, 2012).  
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Part of the reduced performance in the 6MWD may be due to a decrease in maximal 
heart rate over the 5-year period, as it has been suggested that the walking speed 
occurs at around 83% of maximal heart rate (Manttari et al., 2018). In Chapter 4 it was 
found that older people walked at an even lower percentage of their maximal heart 
rate, suggesting that something else than cardiovascular limitations may diminish 
walking speed, such as limited range of motion and pain. 
Besides the above factors, decrements in muscle mass and function may contribute 
to a reduced performance in daily life activities (McPhee et al., 2016, Reid and 
Fielding, 2012, Larsson et al., 2019). In contrast to previous studies (Bijlsma et al., 
2014, Janssen et al., 2002), we found no relationship between muscle mass and 
functional capacity at both baseline and follow-up. In fact, muscle functional capacity 
is more important in this older population to perform daily life activities than muscle 
mass per se, with power and MVC reported to correlate better in older people (Reid 
and Fielding, 2012, Maden-Wilkinson et al., 2015), something we also observed in our 
work. 
Power appeared to be the strongest predictor of 6MWD and TUG performance. 
Therefore, in Chapter 4 the influence of the two components of muscle power, force 
and velocity, for performance were studied. It was found that the velocity of take-off 
during a counter movement jump was  correlated with functional performance at both 
baseline and follow-up, and it was concluded that this was due to both a loss of force 
and an intrinsic slowing of the contractile properties, as suggested previously (Maden-
Wilkinson et al., 2015, Macaluso and De Vito, 2004). However, in the 5-year follow-up 
study, no significant changes in the body mass:maximal force ratio (Fig. 4.2) were 
found, suggesting that the slower velocity at take-off was due to either an increased 
body mass and/or weakening of the muscle, but no further slowing of the muscle. As 
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there was a 12% reduction in force and no significant change in body mass over the 
5-years, the lower shortening velocity was a consequence of decreased force 
generating capacity. The apparent slowing of the muscle is thus due to the muscles 
working a relatively higher load (due to the loss muscle strength), leading to slower 
contraction according to the force-velocity relationship. The findings in chapter 3 and 
4 allow more targeted exercise interventions in older populations, to help delay the 
onset of mobility issues and transition to a dependent lifestyle.    
5.3 Limitations and directions for future research 
This thesis showed significant loss of muscle mass and function, and functional 
capacity in septuagenarians in as short a period as 5 years. However, a number of 
fundamental questions are still unresolved. This work suggested accelerated ageing 
when individuals reach their eighth decade and in line with previous literature (Mitchell 
et al., 2012, Ganse et al., 2018, Degens and Korhonen, 2012). However, it needs to 
be confirmed through further studies in changes occurring from the fifth decade, 
characterising middle age and more work in those progressing into and past their 
eighth decade to provide insight into when this accelerated period of ageing begins or 
if it is present at all. All participants within the study were living independently and in 
relatively good health, and therefore the model of ageing described here may not be 
representative for wider population. We must consider that even though the model of 
ideal ageing may be linear, the majority of individuals will not follow a linear path. Life 
events such as illness or surgery are likely to have key impacts into how people age 
and changes in musculature and it is important that these changes are characterised 
alongside looking at frail or more severely sarcopenic individuals. It should also be 
noted that investigation of habitual physical activity was not conducted; therefore, it 
cannot be assumed that the loss of muscle mass and function seen within this work 
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were solely down to the normal ageing process, as they may have been changes in 
habitual physical activity that either accelerated or blunted these processes. It has 
been shown that the maintenance of physical activity is key in older individuals and 
that as little as two weeks reduced step count contributed to reductions of muscle 
mass and perturbations in other key process key in muscle maintenance (Breen et al., 
2013). Such individuals may suffer from varying ailments that may accelerate muscle 
wasting and hence the rate of ageing. Such people, and even healthy older people as 
in our study, may improve their muscle function and quality of life by improving muscle 
function by e.g. aerobic & power training. Indeed, the efficacy of resistance training 
programmes to improve muscle mass and strength has been shown in older people, 
and even those with cancer, joint replacements etc. (Reeves et al., 2004b, Nilwik et 
al., 2013, Doherty, 2003a). However, these benefits do not stop the loss of function 
with ageing, with master athlete’s still experiencing loss in endurance, strength and 
power. The maintenance of physical activity is also not enough to maintain muscle 
mass with ageing , with only an increased load of physical activity able to attenuate 
these changes over and above ‘leisure time’ activity (Mitchell et al., 2003). Resistance 
training is thought to lead to a decrease in catabolic and increase in anabolic pathways 
(Ribeiro et al., 2017). Increasing protein synthesis, tempering anabolic resistance 
(Schulte and Yarasheski, 2001), as well eliciting changes in the neuromuscular system 
(Taaffe et al., 1999), with these factors all lessening the impact of ageing on muscle 
quality and consequently mobility related issues. It is also important to consider the 
benefits of aerobic exercise on ageing muscle, alongside the cardiovascular 
conditioning it provides. Cross sectional area of older human muscle fibres and 
hypertrophy have been reported through the administration of aerobic exercise  
(Konopka et al., 2013). These effects are principally through an increase in 
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mitochondrial biogenesis, with long term aerobic exercise programmes decreasing 
ROS production in older people, alongside the benefit of reduced abdominal fat  
(Konopka et al., 2013, Short et al., 2003). To enhance the benefits of such 
programmes nutrition also needs to be considered in light of the anabolic resistance 
reported in old people (Rennie, 2009, Breen and Phillips, 2013). This may include 
increased protein intake and the supplementation of omega-3 fatty acids that further 
improve muscle mass and decrease fat mass (Park et al., 2018, Smith et al., 2011). It 
has been shown that a low protein diet can be detrimental and is linked with frailty in 
older adults (Coelho-Júnior et al., 2018). Increasing protein intake in older people can 
overcome anabolic resistance in older people, therefore increasing protein synthesis 
and muscle mass (Moore et al., 2015). Essential amino acid (EAA) profile should also 
be considered, as without complete EEA profile maximal protein synthesis cannot be 
achieved, with leucine being the key regulator of protein synthesis from ingested 
proteins (Volpi et al., 2003, Devries et al., 2018). All of which highlight the importance 
of regular physical exercise, healthy diet and low body fat in old age, to maintain 
muscle mass and function (McPhee et al., 2016, Mithal et al., 2013).  
Although it was found that DXA can be used to assess the changes in body mass in 
an older populations, it consistently overestimates the actual muscle mass in 
comparison to the gold standard, MRI (Abe et al., 2015, Loenneke et al., 2016). This 
then will result in an underestimation of the specific force of muscle, which should be 
considered when comparisons are made with other values of specific force in the 
literature. The cause of this overestimate is as yet unknown. 
The use of a single measure of mobility has limited value to identify those who have 
sarcopenia (Looijaard et al., 2018). Indeed, the most widely used criteria to define 
sarcopenia include a battery of measurements, such as functional performance, 
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muscle mass and muscle strength (Fried et al., 2001, Cruz-Jentoft et al., 2019). Also 
in this study more than one functional measure was used (6MWD and TUG) and 
related to muscle function. The strength of our work is that we were able to disentangle 
the contributions of force generating capacity and intrinsic slowing of the muscle to the 
age-related reduction in power, something rarely considered. 
Voluntary activation measurement using twitch interpolation has been shown to have 
good intra-rater reliability (correlation coefficients > 0.80), though we should be aware 
that methodological flaws may cause issues with this measurement, such as resting 
twitch, stimulation location, inadvertent stimulation of antagonists and joint angle 
(Nuzzo et al., 2018).    
5.4 Conclusion  
The thesis’s overall aim was to characterise the relationship between loss of mass and 
function with functional performance measures in UK-based septuagenarian men and 
women during a 5-year longitudinal study. It was found that DXA showed a similar 
percentage atrophy as MRI, demonstrating that DXA can be used to assess 
longitudinal changes in muscle mass in older people. The rate of muscle wasting was 
independent of baseline muscle mass in both sexes, a higher baseline body fatness 
led to a greater rate of muscle wasting in men. The annual percentage decline in 
muscle mass during the 5-year period was larger than that seen between people in 
their twenties and seventies (Maden-Wilkinson et al., 2015). 
Significant decrements in mobility performance were reported in both genders that 
was to some extent attributable to an age-related decline in maximal heart rate and 
balance. The most significant contributor to the decreased performance in the 6-min 
walk and timed up-and-go tests was the age-related decline in muscle power. It 
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appeared that this loss of power in the 5-year follow-up was primarily due to a 
reduction in MVC rather than intrinsic slowing of the muscle that seemed to play a 
significant role during early ageing (Maden-Wilkinson et al., 2015).  
The loss of force was a consequence of both a reduction in muscle mass and muscle 
quality (specific force; force per muscle cross-sectional area), and a minor contribution 
of a reduced ability to fully activate the muscle. This loss of muscle mass was the 
result of preferential type II atrophy and loss of fibres. The findings within this thesis 
have implications for the design of interventions to mitigate these age-related changes 
even in a septuagenarian population in relatively good health, delaying the transition 
from independent living to dependent living.   
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Appendix 1 
 
Reproducibility of contractile properties of the human quadriceps 
muscle in healthy young subjects 
 
Introduction 
The use of electrical stimulation techniques to assess human muscle contractile 
properties has been well established (Gerrits et al., 2001, Chan et al., 1999, Hunter et 
al., 1999, Degens et al., 2005, Morse et al., 2007b, Wust et al., 2008). Electrical 
stimulation allows the determination of muscle contractile indices such as force 
frequency relationship, fatigue index, maximum rate of contraction and maximum rate 
of relaxation, while avoiding possible motivational bias. The contractile properties 
determined in this way appear to correlate with a variety molecular or histochemical 
muscle features (Harridge et al., 1998).  
When performing repeated measures it is important to know how reproducible the 
measurements are. This is particularly important when one wants to know the impact 
of an intervention on the contractile properties of the muscle, especially when one 
considers muscle may adapt quickly to changes in functional demands (Baar and 
Hargreaves, 2011, Koopman and van Loon, 2009).  
The aim of this study was to assess the reproducibility of the measurement of 
contractile properties by electrically elicited contractions over two testing sessions, 
spaced by 2 weeks.  
 
Methods 
Participants  
Nine individuals (8 men and 1 woman) participated in the study. The study was 
approval by the ethical committee of Manchester Metropolitan University and was 
performed in accordance with the Helsinki Declaration. Descriptive data of the subjects 
is presented in table 3. All subjects were healthy and were recreationally active as 
assessed with health and physical activity questionnaires (Baecke et al., 1982). 
141 
 
Exclusion criteria were known cardiovascular, respiratory conditions, neuromuscular 
diseases and lower limb injuries.  
Table 3. Characteristics (mean ± SD) of participants.  
 Age (yrs) Height (m) Mass (Kg) BMI Body Fat % 
N = 9 27.6±3.7 178±5 84.5±7.2 26.8±2.9 18.6±8.6 
 
Procedure 
Isometric knee extensions were performed with the right leg on a custom made 
isometric testing dynamometer (Designed by the Department on Physical and Medical 
Technology, VU University, Amsterdam, The Netherlands). Force signals were 
recorded via a customised Labview (National Instruments Corporation, Texas, USA) 
and Matlab software (Matlab, the Mathwork Inc, S Natik, MA, USA). All procedures 
were explained to the participants, emphasising the requirement to stay relaxed during 
electrically stimulated contractions and only to voluntary contract when instructed. The 
patients were seated on the dynamometer with a knee angle of 90° (Full extension 
being 0°) and 85° hip flexion (Supine being 0°). The lower leg of the participants was 
securely fastened to the force transducer, 2 cm above the ankle malleolus. The hip 
joint was held in place firmly via a strap. Prior to procedures participants were 
familiarised to the knee extension exercise, initially with three contractions around 50% 
of maximal effort lasting 3 seconds, followed by two further contractions around 80% 
maximal effort. A two-minute rest was given prior to a maximal voluntary contraction 
sustaining for around 3 seconds. Two or more maximal effort contractions were 
performed until the two highest values were within 10%, with the highest value taken 
as MVC. Verbal reinforcement and visual feedback were conveyed during the testing.  
Voluntary activation, the ability to voluntarily activate the knee extensor muscles during 
an MVC was assessed with the interpolated twitch technique (Wust et al., 2008, 
Rutherford et al., 1986a, Van Leeuwen et al., 2012). Thereto, stimulation electrodes 
(AmericanImex, CA, USA) were placed on the proximal and distal heads of the 
quadriceps femoris muscles. Muscles were stimulated with 400 V pulses with a width 
of 200 µs (Digitimer DS7AH, Herts, UK). Before the test the current was increased so 
that a stimulation with two pulses separated by 10 ms known as a “doublet” elicited ≥ 
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30% MVC. During the test, the doublet was followed by an MVC and at the peak of 
the MVC another doublet was administered. The voluntary activation (VA) percentage 
was calculated as: 
VA = 100 * (1 – t/T) 
Where T is the value of the resting doublet and t is the amplitude of the superimposed 
doublet (McPhee et al., 2014, Wust et al., 2008). 
To construct the force frequency the muscle was stimulated with 2-second tetani (1, 
10, 15, 20, 30, 50 and 100 Hz) in a random order with a 60 second rest in between. 
The maximal force at each frequency was expressed as a percentage of the force 
evoked at 100 Hz (Figure 1). Contraction rate (delta force/ delta time, max), normalised 
contraction rate (contraction rate/peak force), relaxation rate (delta force/delta time, 
min) and normalised relaxation rate (relaxation rate/peak force) were calculated from 
the 100Hz contraction (Degens et al., 2005, Wust et al., 2008).   
To determine the fatigue resistance of the muscle the muscle was stimulated with 30-
Hz pulse trains 1 s on 1 s off for 4 min. The resistance to fatigue was expressed as a 
fatigue index, which was calculated the 30 Hz force of the last contraction (Fend) as a 
fraction of the 30 Hz force of the first contraction (Fstart) fatigue index = Fend/Fstart 
(McPhee et al., 2014, Degens et al., 2005) 
Statistical Analysis 
A paired samples T-Test was used to assess differences between testing sessions 
using SPSS v21 (IBM, USA). Data are given as mean ± standard deviation (SD). R² 
values were calculated and differences between groups were considered significant 
at P<0.05. Moreover, the test – re-test variability was assessed for the entire group 
using pooled coefficient of variation (CVp), which was calculated as the SD of the 
differences as proportion of the mean.  
CVp = √((∑CVᵢ²)/n) 
(Gerrits et al., 2001) 
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Results 
Table 4. Descriptive statistics and reproducibility of contractile properties of human 
quadriceps muscle in healthy young subjects.  
 
 
Test Mean ± SD CVp R² P 
      
MVC (Nm) Pre 836±110 0.07 0.61 0.317 
 
Post 811±101  
  
      
FI Pre 0.52±0.10 0.08 0.71 0.441 
 
Post 0.53±0.08 
   
      
VA (%) Pre 85.7±11.5 0.06 0.69 0.362 
 
Post 83.6±10.5 
   
      
dF/dt Max 100Hz  
Pre 15.8±0.9 0.08 0.890 0.394 
Post 16.4±1.5 
   
      
dF/dt Min 100Hz  
Pre -14.3±1.2 0.13 0.100 0.832 
Post -13.9±1.7 
   
 
MVC: maximal voluntary contraction, FI: fatigue index, VA: voluntary activation, dF/dt 
max: most force rising ratio, dF/dt min: most force relaxation ratio, CVp: pooled 
coefficient of variation. 
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Figure 5. Force frequency repeatability relationship of contractile properties of human 
quadriceps muscles in healthy young subjects. 
Nine participants completed experimental tests for both testing days, where 6 also 
completed repeat tests for the force frequency relationship, and rates of force rise and 
relaxation. Table 4 shows that the different contractile properties measured in the first 
test correlated well with those in the second test (all R² > 0.6), and did not differ 
significantly. Figure 5 illustrates the excellent level of agreement between test 
sessions for the force frequency relationship.  All bar the maximal rate of relaxation 
returned CVp’s less than 0.09  
Discussion 
The main finding of the present study is that the contractile properties determined with 
electrically elicited contractions are highly reproducible in a period as long as 2 weeks, 
the coefficient of variation was less than 9% for all parameters, except the relaxation 
rate. 
The coefficient of variation in our study for the determination of contractile properties 
with electrically evoked contractions was lower than that reported previously (Gerrits 
et al., 2001, Brass et al., 1996, Chan et al., 1999, Eerbeek and Kernell, 1991). Some 
of the variability in the test-retest measurements could be due to the incomplete 
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stimulation of the muscle via the surface electrodes which leaves some room for 
voluntary contractions interfering with the measurements (Gerrits et al., 2001).  
It must be considered that some of the variation could arise from small differences in 
experimental environment, changes in the condition of the muscle due to previous 
activity, changes in dietary or hydration state. It is also possible that different fibres 
were recruited during the two sessions, though care was taken to position the 
electrodes at exactly the same locations on the muscle and use a current to elicit the 
same absolute force. In theory, muscles may have adapted to some training regime 
that was initiated, but we asked our participants to maintain their normal habitual 
activity levels, therefore we assume no changes.   
In conclusion the current study confirms that in young healthy subjects the contractile 
properties of the quadriceps muscle can be determined with electrically evoked 
contractions via surface electrodes to a high level of reproducibility.  
 
